TSS:Rfhg 130327.1

Basic information about the TSS

---

TSS ID: rfhg_130327.1 Species: human Chr: chr10		Start: 112950302 End: 112950310 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: FJ010174:0 GeneID: 6934 HGNC/MGI_ID: HGNC:11641 UniProt_ID: Nearer transcript ids and distances:

Gene_name: TCF7L2 Gene_symbol: TCF7L2 Gene_synonyms: TCF-4 Gene_source: HGNC:11641

TATA-Box annotation

---

Distance to TSS:	56
Nearest PromoterID:	NM_001363501
Entrez ID:	6934
Nearest Unigene:	Hs.593995
Nearest Refseq:	NM_030756
Nearest Ensembl:	ENSG00000148737
Gene Name:	TCF7L2
Gene Alias:	TCF-4|TCF4
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TCF7L2 p2@TCF7L2 p3@TCF7L2 p4@TCF7L2 p5@TCF7L2 p6@TCF7L2 p7@TCF7L2 p8@TCF7L2
Sample		p1@TCF7L2	p2@TCF7L2	p3@TCF7L2	p4@TCF7L2	p5@TCF7L2	p6@TCF7L2	p7@TCF7L2	p8@TCF7L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	39.16	13.83	0.39	1.95	1.17	1.17	1.95	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.94	7.69	0.40	3.24	1.42	1.01	1.62	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.04	15.24	0.58	2.51	0.96	0.77	0.58	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.42	10.40	0.83	1.25	0.42	0.00	1.04	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	39.14	7.87	1.35	1.57	1.35	0.90	2.02	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.65	6.59	0.58	1.16	0.78	0.78	2.52	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.25	6.10	0.65	3.92	0.87	0.87	4.14	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.04	5.57	0.97	0.97	1.70	0.97	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	22.65	4.92	0.43	0.85	0.85	0.43	2.14	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	6.96	0.58	2.32	1.74	0.00	4.06	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.57	7.28	1.62	4.04	0.00	0.81	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	45.53	8.13	0.81	1.63	0.41	1.22	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	60.29	20.79	1.93	5.80	1.61	0.48	1.29	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	64.95	22.55	3.01	3.01	3.61	0.60	0.45	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	57.08	21.30	3.29	6.59	1.10	1.32	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.63	21.38	3.77	4.78	1.76	0.25	1.01	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	55.69	16.82	4.59	6.33	4.37	0.44	1.09	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.52	13.50	2.53	8.86	2.53	0.42	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	67.71	18.66	4.80	3.20	4.80	0.53	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.32	18.05	4.06	4.06	1.81	0.15	0.60	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	42.77	11.23	1.74	4.68	2.27	0.40	0.40	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	63.35	19.85	2.24	4.66	2.76	0.86	0.86	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	45.76	13.57	3.49	4.78	2.46	0.65	0.65	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	42.47	14.56	3.64	4.13	1.94	0.00	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	50.82	19.35	2.06	4.64	2.32	1.03	0.77	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	44.94	14.24	4.11	4.75	2.85	0.95	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	70.88	15.93	3.85	3.30	1.65	0.00	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	44.32	19.80	2.59	3.77	1.65	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.66	9.69	1.94	3.07	1.29	0.32	0.48	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.41	14.48	1.27	2.17	1.99	0.36	0.54	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.87	8.37	2.51	2.72	1.47	0.21	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.82	7.23	1.37	2.34	0.98	0.00	0.98	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.48	9.50	2.11	3.80	0.84	0.84	1.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.95	7.26	3.46	3.46	1.65	0.99	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.10	9.35	0.56	1.68	2.06	0.56	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	28.74	7.47	1.72	1.92	1.34	0.57	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	28.82	6.34	1.84	2.25	1.84	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.37	4.63	2.42	1.21	1.61	0.60	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.31	3.51	1.08	0.81	0.54	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.45	3.12	0.96	1.20	0.24	0.00	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.47	2.82	2.35	1.65	0.94	0.00	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.89	1.76	1.46	1.61	1.02	0.15	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.05	5.91	2.53	2.32	1.69	0.42	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.45	4.72	2.27	1.57	1.22	0.35	0.70	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.10	6.63	1.00	1.81	0.40	0.40	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.66	6.75	1.86	1.63	0.70	0.23	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	26.63	4.56	4.08	0.72	0.96	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.76	2.68	2.68	1.79	0.30	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	33.27	5.03	3.59	2.39	0.72	0.00	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.36	5.66	2.02	1.01	2.22	0.40	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.67	11.48	1.43	2.46	1.23	1.02	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	43.14	8.89	0.67	1.56	2.45	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	27.98	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.87	8.16	0.35	1.42	2.84	1.06	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	24.19	7.62	0.66	0.99	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32.72	3.36	2.52	3.36	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	54.65	6.43	0.46	1.84	3.21	1.84	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.81	11.34	1.62	2.59	2.92	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.37	7.71	0.00	4.50	0.96	0.00	0.32	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.30	13.20	1.26	2.51	3.46	1.89	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.71	7.05	0.00	0.71	0.71	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.96	7.85	0.00	1.12	2.24	0.56	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	62.90	11.94	1.59	2.39	1.59	3.98	0.80	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	55.04	9.17	0.34	1.70	1.36	1.36	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	63.36	13.65	3.25	1.95	2.92	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.04	5.68	2.48	2.84	2.48	0.35	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	16.16	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	15.79	39.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.63	2.93	0.00	0.00	1.95	0.49	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.34	4.96	0.50	0.00	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.80	3.28	0.00	0.94	1.88	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.42	8.61	0.00	2.98	3.97	0.33	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.68	8.04	0.62	4.33	2.17	0.00	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	20.79	4.28	1.22	0.92	1.22	0.31	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	36.43	12.20	1.43	1.74	1.11	0.48	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	27.91	8.98	6.42	4.01	0.80	0.64	0.32	0.48
Adipocyte - omental, donor1	11473-119C6	48.86	13.36	3.56	2.16	1.78	0.51	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	12.71	4.48	15.70	1.49	0.75	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	19.76	3.68	16.75	1.34	0.00	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.95	1.91	5.74	0.64	0.64	0.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	2.20	3.30	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	5.87	3.16	0.90	0.45	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	31.80	8.86	7.65	3.48	1.56	0.00	0.70	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	75.49	19.95	7.43	4.11	2.35	0.59	0.78	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	56.88	7.98	0.26	1.03	1.54	1.03	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	52.69	14.50	2.23	4.46	1.39	0.84	1.95	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	81.12	21.75	2.94	3.53	2.35	0.59	2.35	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	76.41	28.15	6.43	3.46	1.45	0.72	0.80	2.25
Adipocyte differentiation, day08, donor2	13023-139D8	76.82	22.92	1.61	2.90	2.58	0.65	0.65	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	73.58	8.00	5.33	0.00	2.13	1.07	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	52.86	10.57	1.67	2.78	1.67	1.11	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	23.29	9.57	4.57	2.08	0.83	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	51.74	16.07	2.01	2.01	1.00	0.25	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	39.60	8.18	2.29	0.98	1.96	0.00	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	42.32	12.48	0.61	2.74	1.22	0.91	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	13.04	6.19	1.10	0.22	0.00	0.22	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	2.51	4.30	0.36	0.00	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	2.40	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.11	6.66	2.70	1.08	0.54	0.36	1.44	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	1.67	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.64	4.93	1.85	0.41	0.21	0.41	0.62	0.41
Anulus Pulposus Cell, donor1	11248-116E6	13.85	3.32	0.46	0.80	0.23	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	5.39	0.24	2.45	0.24	0.00	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	3.15	8.09	0.90	0.90	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	4.78	3.47	1.30	0.00	2.17	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	8.56	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.52	3.59	3.59	1.79	1.20	0.90	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	3.79	5.06	1.26	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	3.96	0.66	1.98	0.66	1.98	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	2.27	2.27	0.32	0.00	1.30	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	2.91	5.34	1.46	0.97	0.49	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	2.38	0.59	1.78	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.68	2.64	3.77	1.51	0.38	1.51	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	3.63	2.18	1.45	0.00	2.90	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	1.25	1.25	1.25	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.51	1.48	1.48	0.66	0.16	0.00	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	5.46	2.73	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.94	4.98	1.66	1.21	0.15	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	4.29	3.21	2.14	0.54	0.00	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.71	3.02	3.78	1.32	0.38	0.38	0.94	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.23	4.01	1.60	2.14	0.27	0.53	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	1.95	2.93	2.93	1.95	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.62	2.65	3.81	1.66	0.66	0.33	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	2.40	0.00	1.20	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	3.54	0.00	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.38	1.54	3.43	2.40	0.17	1.37	1.03	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	2.91	5.34	0.97	0.97	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.62	2.28	4.93	2.28	0.76	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	7.27	2.42	0.00	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	5.13	5.70	1.71	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	2.57	2.78	1.50	0.64	0.21	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	2.58	1.55	1.55	0.00	0.26	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	3.28	1.88	1.41	0.00	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.07	2.25	6.43	1.93	0.32	1.29	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.84	5.71	1.43	4.28	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	1.75	1.75	2.34	0.00	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.15	1.51	4.52	1.51	0.60	0.00	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	2.38	1.19	1.19	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.22	3.05	6.61	1.02	1.02	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.73	2.80	5.09	3.31	0.00	1.27	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	4.45	1.27	1.91	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	4.32	6.47	0.86	0.86	0.43	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.34	2.33	4.66	3.18	0.21	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.63	2.32	0.00	0.58	0.29	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	3.78	4.72	1.89	0.00	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.68	2.03	4.24	2.03	0.51	0.34	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	9.27	0.00	2.32	0.00	2.32	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	0.00	6.34	2.11	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.86	1.29	5.15	0.86	0.64	0.64	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	2.41	0.60	1.20	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	2.19	2.92	0.00	0.73	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.82	2.53	2.30	0.69	0.92	0.92	0.92	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	4.07	0.51	0.51	0.25	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.91	1.03	2.89	1.24	0.21	0.62	0.83	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.96	3.37	0.61	0.92	0.31	0.31	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	2.87	2.87	0.96	0.48	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.98	2.22	4.21	0.89	0.22	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	3.05	0.00	1.53	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	2.77	3.88	0.55	0.55	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.74	1.59	2.12	1.32	0.26	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	1.45	0.73	1.09	0.36	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	29.23	18.18	16.09	0.37	0.61	0.61	0.61	0.37
Astrocyte - cerebellum, donor2	11580-120F5	8.90	1.54	5.48	0.51	0.17	0.34	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	38.59	18.25	2.31	2.52	1.26	0.21	0.00	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	12.20	21.61	2.44	0.70	0.70	0.70	0.00	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	11.81	12.78	0.97	1.29	0.65	1.13	1.29	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	7.31	5.97	0.30	1.04	0.15	0.45	1.94	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.23	0.11	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.38	0.00	0.13	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.23	0.00	0.11	0.11	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	101.21	23.01	2.62	2.35	4.97	0.00	0.26	1.83
Basophils, donor2	12242-129H1	112.57	18.04	3.25	8.30	3.25	1.80	0.00	0.36
Basophils, donor3	12243-129H2	84.52	14.26	9.41	3.09	2.20	1.76	0.15	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	5.82	4.53	1.72	0.00	0.65	0.43	0.43	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	0.00	5.03	0.91	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	1.88	2.51	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.57	1.46	1.87	0.21	0.21	0.42	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	4.38	0.92	1.61	0.46	0.00	0.46	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	5.04	1.98	1.80	0.36	0.36	0.54	0.18	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.49	0.23	0.70	0.23	0.23	0.93	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.17	6.40	0.96	0.64	0.32	1.60	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	266.56	34.94	13.53	18.03	14.65	3.38	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	266.34	31.92	20.60	16.89	15.96	3.71	0.56	2.23
CD14+ Monocytes, donor3	11381-118B4	255.76	28.76	3.29	19.32	14.05	3.73	0.88	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.68	0.00	0.00	0.57	0.57	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.20	1.14	0.76	0.38	0.00	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.59	0.66	0.00	0.00	0.00	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	37.44	2.02	2.60	1.30	0.72	0.58	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	48.88	4.22	4.22	1.21	0.30	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	82.20	7.82	3.79	2.37	1.66	2.84	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	62.10	3.85	4.18	2.51	0.67	1.84	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	56.31	3.31	2.76	1.38	0.28	0.55	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	103.63	7.69	5.70	2.48	1.24	1.98	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	42.29	2.74	2.15	2.94	0.98	0.59	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	65.17	3.03	2.49	3.03	1.60	0.53	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	110.56	7.62	2.18	1.74	1.31	0.65	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	131.11	8.43	5.62	4.68	1.64	0.94	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	164.74	10.56	11.09	2.11	4.75	1.06	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	155.31	13.31	14.42	2.22	0.00	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.79	2.23	2.38	2.08	0.45	0.45	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	23.15	1.60	2.20	0.60	0.00	0.60	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	62.04	4.37	0.21	0.83	1.25	0.42	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	154.43	9.84	10.75	9.38	2.52	1.83	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	165.36	11.99	2.49	1.81	1.36	0.68	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	225.21	17.89	9.17	7.86	3.49	1.31	0.87	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	32.28	2.96	2.69	0.54	1.34	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	61.76	3.14	3.84	2.97	0.87	1.57	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	91.32	9.26	6.31	1.68	0.42	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	122.17	5.14	9.74	7.72	1.84	1.10	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	181.06	7.40	10.57	2.47	1.41	2.47	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	296.58	14.48	6.14	4.39	4.39	3.95	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	38.19	2.44	1.74	2.09	1.22	0.70	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	56.87	2.97	5.20	3.35	0.74	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	123.94	9.05	1.72	0.86	1.51	0.86	0.22	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	117.11	6.96	8.19	2.46	0.82	1.64	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	182.89	7.88	1.62	1.62	1.39	2.55	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	277.93	12.30	2.32	3.02	1.86	2.09	0.23	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	279.21	93.29	8.28	3.49	8.28	2.18	0.00	4.36
CD14+CD16+ Monocytes, donor2	11801-124D1	281.12	85.47	20.79	9.01	14.55	2.31	0.00	4.62
CD14+CD16+ Monocytes, donor3	11912-125G4	171.56	53.72	4.12	3.03	6.93	1.52	0.00	2.82
CD14+CD16- Monocytes, donor1	11788-124B6	97.33	6.07	2.34	2.02	2.18	1.56	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	65.67	6.99	4.19	1.92	1.40	0.70	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	141.81	9.36	0.67	1.56	1.78	2.68	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	380.72	132.69	21.69	11.23	14.29	1.53	0.00	5.36
CD14-CD16+ Monocytes, donor2	11800-124C9	417.17	160.28	35.79	16.69	17.57	1.10	0.00	9.00
CD14-CD16+ Monocytes, donor3	11911-125G3	420.67	182.12	9.69	11.37	13.69	1.05	0.00	9.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1.60	0.00	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	1.57	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	0.82	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	10.16	1.45	0.00	0.00	0.73	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	4.54	0.50	0.50	0.50	1.01	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	38.15	1.00	1.00	0.00	1.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	88.20	7.30	25.28	1.12	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.16	4.51	1.50	1.50	0.00	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.32	5.64	0.45	0.90	0.68	1.58	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	9.28	0.71	0.36	0.71	0.00	1.43	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	7.35	0.61	1.22	2.45	0.00	2.45	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	6.71	0.30	0.00	0.91	0.00	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	13.75	1.42	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2.81	0.00	0.00	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1.79	0.00	0.45	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.35	0.00	0.00	0.00	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	0.00	0.00	0.44	0.00	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	6.25	0.27	0.00	0.27	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	9.11	0.54	0.00	0.00	0.00	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.09	0.00	0.51	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.87	0.43	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5.67	0.44	0.00	0.00	0.00	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.39	0.99	0.00	0.00	0.49	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	0.00	0.00	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	0.00	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.57	1.38	6.65	0.00	0.00	1.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.31	0.25	1.23	0.25	0.00	1.47	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	17.91	1.79	0.36	1.07	0.00	1.43	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	9.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	28.48	1.96	2.29	1.96	0.00	2.29	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	26.66	0.75	1.88	4.13	0.38	2.25	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	28.78	1.01	0.50	2.78	1.01	3.03	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.28	0.92	0.00	0.00	0.00	0.23	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.12	0.48	0.00	0.00	0.00	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.65	0.55	0.00	0.00	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	0.30	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.08	0.24	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.87	0.45	0.00	0.00	0.00	0.45	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.52	1.30	0.00	0.43	0.22	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.26	1.05	0.00	0.53	0.00	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.63	0.23	0.00	0.70	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.23	1.51	0.00	0.91	0.00	0.00	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.49	0.58	0.00	1.16	0.29	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.26	1.87	0.00	0.00	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.27	3.50	0.44	1.75	0.44	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	4.55	0.91	0.00	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	4.48	0.00	0.75	0.75	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.76	0.36	0.00	0.36	0.00	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.03	0.58	0.00	0.86	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.54	0.47	0.00	0.47	0.24	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.80	0.95	0.00	0.00	0.00	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.61	0.92	0.00	0.00	0.31	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.69	0.64	0.32	0.64	0.32	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.03	1.53	0.38	0.38	0.38	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.88	1.18	0.00	0.00	0.00	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	0.76	0.00	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	42.56	3.21	0.80	0.80	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	4.20	1.40	4.20	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	48.08	6.01	0.00	1.00	0.00	1.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	93.21	27.42	7.31	3.66	0.00	3.66	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	17.79	5.93	0.49	0.99	0.00	0.00	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	12.10	2.00	2.84	0.84	0.32	0.63	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	29.12	9.01	14.91	1.04	0.00	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	20.26	8.17	1.78	0.00	0.71	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	19.00	6.71	1.02	2.96	1.14	0.23	0.34	0.11
Chondrocyte - re diff, donor2	11339-117F7	85.05	37.60	0.00	3.58	3.58	0.90	2.69	2.69
Chondrocyte - re diff, donor3	11411-118E7	79.26	9.30	1.62	2.43	1.21	0.81	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	38.90	17.79	1.61	2.07	2.30	0.46	0.69	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	21.38	8.34	1.50	1.50	0.43	0.21	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	18.67	7.52	0.53	1.59	0.27	0.88	0.71	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	73.18	17.79	2.75	1.93	1.01	1.83	1.74	1.83
Corneal Epithelial Cells, donor1	11526-119I5	8.12	4.61	0.44	0.00	0.44	0.44	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	13.65	11.38	1.14	1.14	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.65	5.62	1.28	1.53	0.26	0.51	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.16	0.17	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.26	0.00	0.00	0.32	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.54	0.00	0.00	0.11	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.59	3.42	1.71	0.34	0.34	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2.42	0.00	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.34	5.67	0.17	1.00	1.17	0.33	2.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	2.93	1.17	0.00	0.59	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	3.39	1.13	0.00	0.85	0.57	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	4.33	0.39	0.00	0.00	0.79	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.89	3.49	3.20	0.29	0.87	0.58	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.94	2.59	0.71	1.41	0.24	0.24	1.65	0.24
Endothelial Cells - Artery, donor3	11413-118E9	15.25	6.84	0.70	0.18	0.70	0.53	1.23	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.17	5.76	0.66	1.11	1.11	0.44	1.77	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.34	5.48	1.22	0.00	0.30	1.22	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.37	5.36	1.13	0.28	1.69	0.56	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	1.78	7.13	0.00	0.59	0.30	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	3.64	0.52	0.00	0.00	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	7.37	4.25	0.57	1.13	0.14	0.85	2.98	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	9.60	4.80	8.40	0.80	0.40	1.20	2.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	12.05	1.05	0.00	0.00	0.00	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	23.23	10.19	0.99	1.37	1.74	1.12	3.35	1.74
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.47	4.56	1.30	0.87	1.30	0.43	2.61	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.43	5.74	0.24	0.61	0.85	1.83	3.79	0.49
Endothelial Cells - Vein, donor1	11267-116G7	12.51	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	2.10	0.00	0.00	0.00	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	6.44	2.04	0.00	0.16	0.31	0.47	0.63	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	435.67	23.10	6.60	4.95	3.30	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	292.48	7.13	7.13	3.57	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.48	10.02	1.47	0.49	0.24	0.00	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	69.38	9.85	6.16	4.52	1.23	1.64	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.34	1.42	0.00	0.44	0.00	0.22	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.35	5.53	1.41	0.87	1.41	0.65	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.28	7.88	1.21	1.21	0.12	0.61	0.73	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.39	6.14	5.05	1.50	0.82	1.36	0.96	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.34	2.95	1.69	1.16	0.42	1.27	0.63	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	39.00	5.27	24.50	1.32	0.53	1.32	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.60	5.32	2.66	1.33	1.33	1.99	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.79	1.81	3.18	0.91	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	7.58	6.06	3.03	0.00	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.63	1.42	0.00	0.16	0.00	0.47	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	49.10	12.43	3.33	0.61	1.21	2.12	1.21	1.82
Fibroblast - Cardiac, donor5	11456-119A7	10.03	1.90	4.31	0.51	0.00	0.89	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	15.92	3.34	4.70	0.61	0.61	0.15	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	31.09	11.39	20.90	0.40	1.07	0.80	0.00	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	28.04	15.53	1.73	0.86	1.29	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	4.39	1.46	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.91	15.91	2.08	0.46	0.92	0.46	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	25.95	12.72	0.85	1.70	1.36	0.34	0.34	0.51
Fibroblast - Dermal, donor1	11269-116G9	3.52	1.64	1.88	0.70	0.00	0.47	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	8.49	4.72	0.00	0.47	0.47	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.59	1.81	0.00	0.48	0.24	0.60	0.60	0.36
Fibroblast - Dermal, donor4	11450-119A1	12.21	4.86	6.78	0.68	0.45	0.57	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	10.29	3.66	5.93	0.87	1.05	0.52	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	13.32	5.20	8.77	0.81	0.65	0.16	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.32	9.79	0.21	1.25	0.62	0.83	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	35.37	11.79	2.62	2.36	1.83	1.57	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	6.19	3.69	1.32	1.84	0.66	0.13	0.66	0.92
Fibroblast - Gingival, donor3	11394-118C8	20.79	4.35	0.10	0.87	0.39	0.77	1.64	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	6.23	1.04	0.00	0.00	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.21	5.46	0.35	2.11	0.35	0.18	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.98	7.02	3.74	1.25	0.62	0.62	1.25	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.80	5.00	2.98	0.95	0.54	0.95	0.54	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	5.29	3.88	0.35	1.76	2.12	6.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.91	5.56	2.49	0.88	0.58	0.44	0.73	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.36	7.09	0.55	1.23	0.68	1.09	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.16	6.14	2.19	0.77	0.77	1.43	2.08	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	54.59	11.74	5.87	2.35	1.91	0.29	1.17	0.73
Fibroblast - Lung, donor1	11270-116H1	14.95	2.72	1.36	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	4.48	2.98	0.00	1.49	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	10.34	2.53	0.21	0.21	0.63	1.69	1.48	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	38.32	7.50	16.66	0.00	2.50	5.00	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	2.80	6.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	1.96	1.12	0.28	0.00	0.56	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.06	12.18	1.62	1.22	1.62	0.81	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	23.97	7.99	3.99	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.77	8.34	0.78	1.16	1.16	0.19	0.97	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	17.29	8.04	2.43	1.67	0.91	0.76	1.37	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.58	7.96	0.92	0.31	0.61	0.00	1.53	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.17	6.49	0.76	0.38	0.38	0.00	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.58	5.13	2.16	2.16	0.54	1.08	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.87	3.13	0.12	0.58	0.46	0.35	1.16	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.83	3.54	0.22	0.55	0.22	0.22	0.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.31	11.38	2.24	0.61	0.81	0.81	1.83	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	6.01	2.00	0.67	1.34	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.86	7.91	1.19	1.19	0.40	0.00	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.13	7.74	22.42	1.79	0.79	1.79	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	60.21	13.68	3.91	0.71	1.42	0.18	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.41	7.10	2.17	1.38	1.38	0.39	0.39	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	22.26	1.50	11.13	0.30	0.90	1.20	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	40.05	4.53	12.09	0.54	0.22	0.97	0.76	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	44.29	6.58	24.80	2.78	0.51	0.76	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	44.30	8.20	2.95	0.82	1.48	0.16	0.33	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	103.86	29.68	9.02	5.61	3.21	3.21	0.40	1.60
Fibroblast - skin normal, donor2	11561-120D4	46.92	6.43	17.88	0.30	0.50	1.81	0.50	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.66	4.84	27.81	2.12	1.21	2.12	1.81	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	90.47	16.57	5.63	2.65	2.07	0.83	0.50	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	32.99	8.03	18.98	0.34	0.51	0.68	1.03	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	3.61	19.05	0.66	0.33	1.97	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.77	3.20	8.95	0.53	0.32	1.28	0.21	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	19.23	3.71	2.70	0.17	0.84	0.51	0.84	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	34.03	4.70	1.41	1.25	1.25	0.94	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	44.32	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	55.78	30.50	0.00	0.87	1.74	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6.76	5.89	0.52	0.17	0.17	0.17	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.75	9.63	0.52	0.52	0.26	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.69	4.34	0.00	0.00	0.00	0.26	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	97.23	117.13	1.53	7.66	12.25	3.83	0.77	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	119.32	106.56	3.19	15.95	8.93	0.64	1.28	6.38
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	169.73	165.45	3.99	27.96	8.56	3.14	0.29	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	78.87	138.15	5.24	17.92	8.27	2.21	0.83	7.72
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	74.89	140.88	8.45	13.70	7.31	2.97	1.14	8.45
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	127.40	127.79	5.15	12.68	7.93	0.79	0.20	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	79.04	131.90	7.67	13.75	7.40	1.85	0.26	9.52
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	48.92	116.11	7.50	11.09	3.59	2.28	2.94	8.48
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	123.38	130.46	8.40	14.59	11.06	1.33	0.44	5.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.05	27.98	6.50	2.26	2.12	0.99	0.00	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.46	17.36	4.31	1.97	1.72	1.60	0.74	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	30.09	27.67	4.30	3.76	3.49	0.81	0.27	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.22	9.04	2.35	1.12	0.74	0.87	0.62	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	17.03	8.17	2.77	0.83	1.11	0.83	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.04	19.52	2.64	2.24	1.22	0.61	0.20	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.52	13.23	2.51	3.88	1.60	0.91	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	14.95	9.97	3.24	0.87	1.12	1.12	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	25.79	8.96	2.62	1.75	1.31	1.09	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.98	13.30	4.14	2.95	1.77	1.48	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.23	10.17	2.70	0.95	1.11	1.43	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.99	10.95	3.35	2.46	0.22	1.12	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.30	13.91	4.84	2.42	1.21	1.01	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.61	13.91	3.22	0.51	0.51	1.87	1.19	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	34.76	28.38	3.19	2.22	1.86	1.77	0.35	1.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.08	31.11	3.02	3.75	1.77	0.83	1.46	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.42	32.79	2.56	1.37	2.22	1.54	1.02	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.48	14.61	2.32	0.66	1.33	0.33	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.78	26.12	2.66	3.08	2.16	0.58	0.58	1.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.04	26.34	1.63	0.41	1.63	0.82	1.23	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.42	16.30	3.92	2.68	2.06	0.83	0.62	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.06	12.91	2.77	1.96	0.92	1.73	0.58	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.84	10.17	3.00	1.83	1.33	1.17	0.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.40	10.80	2.42	3.31	1.10	0.22	0.44	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.12	11.44	3.57	1.48	0.49	0.61	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.07	15.07	5.35	1.95	1.46	1.78	0.65	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.77	10.58	2.89	1.92	0.96	0.64	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.52	5.02	1.42	1.04	0.66	0.85	0.57	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.39	8.86	0.47	1.27	0.63	0.63	0.32	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.63	13.38	2.13	2.43	0.91	0.61	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.86	5.65	2.40	0.94	0.52	0.94	0.84	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.39	9.00	1.98	1.54	0.66	0.66	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.15	8.14	2.52	1.68	0.84	0.28	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.39	6.85	2.41	0.37	1.39	0.93	0.74	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.30	8.82	1.07	1.60	1.34	1.07	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.01	6.12	0.77	1.68	0.46	0.92	0.92	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.90	3.63	1.94	0.39	0.52	0.78	1.04	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	6.51	2.17	1.08	0.54	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	30.23	5.71	2.77	1.84	0.92	1.29	0.92	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.22	11.62	1.97	2.41	0.66	1.54	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	11.90	2.98	4.96	0.99	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.43	6.73	2.37	3.83	1.19	0.79	0.53	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	26.03	6.25	1.61	4.04	0.40	0.61	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	101.66	21.10	5.59	3.30	4.57	5.85	3.56	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	34.24	27.47	34.64	1.19	1.00	1.00	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	37.44	30.51	5.24	1.85	2.00	1.23	0.62	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	60.97	57.69	11.46	1.84	4.71	1.84	0.41	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	58.21	58.52	7.20	1.25	2.50	0.63	0.31	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	47.47	38.99	6.22	0.57	1.13	0.28	0.00	3.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.25	46.12	22.14	9.22	3.69	1.38	0.46	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	22.27	2.47	2.47	7.42	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	46.03	34.04	6.58	7.35	2.32	1.16	0.39	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	48.13	3.21	12.84	1.60	0.00	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	36.52	1.74	0.00	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	36.78	27.99	5.86	6.18	1.95	1.30	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.36	43.24	9.88	5.77	1.65	0.41	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	79.97	3.33	0.00	3.33	0.00	3.33	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	41.95	29.36	5.31	4.47	0.84	0.56	0.56	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	32.68	29.42	4.90	7.84	1.31	0.65	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	44.46	36.07	5.03	4.19	2.52	1.68	0.84	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.99	30.85	5.73	6.68	1.91	0.95	0.64	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	38.72	33.97	5.09	5.77	1.02	1.70	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	16.71	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.36	25.20	6.30	6.30	2.29	1.72	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.74	29.30	7.40	6.22	1.78	0.89	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	18.64	0.00	3.39	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.97	37.28	13.25	9.11	2.49	1.66	1.24	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	28.08	37.97	10.59	4.37	2.53	1.15	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54	0.00	0.00	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.60	31.14	11.15	6.15	2.31	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.62	30.32	8.48	6.52	1.96	1.63	0.65	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.75	18.06	0.67	1.34	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.52	34.67	9.25	7.32	1.54	1.16	0.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.60	31.15	8.22	6.16	1.03	3.42	1.71	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	19.88	4.97	7.45	4.97	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	51.43	48.13	11.80	10.85	3.77	0.47	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	33.19	35.61	10.26	7.85	1.21	1.21	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.06	30.52	0.00	0.51	3.05	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	45.87	47.86	8.38	7.18	1.99	1.20	0.80	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.04	26.15	8.39	8.88	3.45	0.99	0.99	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	68.47	33.05	10.62	9.44	2.36	1.18	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.01	31.51	8.17	9.92	0.58	1.17	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	29.41	19.31	15.80	8.78	0.88	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	51.71	19.50	12.72	4.24	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.04	29.85	4.78	5.97	1.79	1.79	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	25.23	10.68	6.79	0.97	1.46	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	3.42	1.14	0.00	0.00	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.13	3.33	4.57	3.33	0.83	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	6.75	1.12	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.93	3.17	0.63	0.95	0.00	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	0.84	1.25	0.42	0.42	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.59	6.85	1.04	2.09	0.81	1.28	0.70	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.28	4.56	1.01	0.17	0.51	0.34	0.51	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.19	5.92	1.14	0.23	0.23	0.68	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	8.85	4.70	0.98	1.31	0.55	0.33	0.55	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.74	4.94	0.43	0.00	0.21	0.86	1.07	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	4.74	2.80	1.08	0.43	0.00	0.65	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.09	3.24	0.75	0.75	0.25	1.00	0.62	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	4.97	1.03	0.17	0.69	0.69	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.05	4.16	0.96	0.64	0.64	0.32	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.23	4.48	11.75	0.56	0.00	0.56	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.88	3.46	0.43	0.87	0.43	1.30	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	7.93	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.92	3.17	2.82	0.35	0.71	0.71	1.41	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.15	5.81	0.00	1.45	0.00	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	4.72	1.05	0.17	0.52	0.70	1.05	0.17
Hepatocyte, donor1	11523-119I2	60.53	42.37	9.68	9.68	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	88.34	47.40	7.54	4.31	3.23	1.08	0.00	2.15
Hepatocyte, donor3	11684-122I1	57.06	42.33	6.75	7.36	1.84	1.23	1.23	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	18.28	4.57	0.65	0.00	0.00	1.96	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	40.20	21.85	2.80	2.62	0.87	1.22	1.05	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.43	4.80	1.65	0.55	0.69	0.55	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	1.38	0.00	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	1.67	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	0.00	1.32	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.78	1.89	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	1.29	0.00	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	2.44	0.81	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.52	0.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	2.77	0.00	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	1.42	0.47	0.00	0.47	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	0.00	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	3.19	0.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	1.43	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	0.00	0.00	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	4.43	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	1.74	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	1.07	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	5.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	3.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.30	6.94	0.90	0.57	0.41	0.24	0.16	0.33
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	3.03	1.42	0.28	0.19	0.19	0.00	0.76	0.00
Keratinocyte - oral, donor1	11251-116E9	13.74	8.74	0.79	0.57	0.23	0.68	0.68	0.23
Keratocytes, donor1	11527-119I6	18.91	8.25	0.69	0.34	0.34	1.38	1.38	0.69
Keratocytes, donor2	11607-120I5	14.06	8.20	0.00	0.00	0.00	1.17	0.00	2.34
Keratocytes, donor3	11688-122I5	9.48	1.19	0.79	0.59	0.40	0.40	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	246.17	118.69	10.99	2.20	13.19	0.00	2.20	6.59
Lens Epithelial Cells, donor1	11529-119I8	8.63	2.16	0.00	1.08	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.22	10.96	2.54	1.61	0.81	0.46	0.81	0.35
Lens Epithelial Cells, donor3	11690-122I7	22.10	5.65	3.33	0.71	0.40	0.61	1.21	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.33	4.62	0.12	0.12	0.24	0.24	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.91	1.95	1.67	1.12	0.00	0.56	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.40	1.42	1.26	1.57	0.31	0.47	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	3.23	1.61	1.08	0.00	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.99	1.58	1.26	0.63	0.00	1.26	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.39	2.26	1.19	0.97	0.00	0.43	0.86	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.34	3.28	0.00	0.82	0.00	0.82	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	1.26	0.76	1.26	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.62	1.55	1.83	1.83	0.28	0.28	1.55	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	3.56	1.19	1.19	0.40	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.79	2.71	0.97	1.36	0.00	0.58	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.81	0.74	1.48	1.48	0.37	0.19	0.74	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.71	3.14	1.39	0.70	0.70	0.35	2.09	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.96	0.95	0.95	0.24	0.72	0.48	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.12	1.24	0.55	0.96	0.27	0.41	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.16	3.39	1.85	0.92	0.31	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.86	3.12	1.25	0.94	0.31	0.62	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.42	3.29	1.65	0.91	0.55	0.55	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.87	1.32	0.99	1.65	0.99	0.66	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	1.76	0.59	1.17	0.00	0.00	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.22	2.74	0.75	0.75	0.50	0.00	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	2.42	0.48	2.42	0.00	0.00	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.96	3.23	0.81	0.81	0.54	0.00	1.62	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.06	2.27	2.88	0.45	0.61	0.30	1.82	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	3.63	0.52	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.49	2.09	1.05	1.05	0.42	0.00	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.01	1.95	1.20	0.75	0.30	0.45	1.20	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.82	2.75	0.00	2.06	0.69	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	2.07	1.32	0.56	0.56	0.00	1.51	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.56	2.01	1.17	1.06	0.21	0.21	0.74	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.36	1.45	0.97	1.45	0.48	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.98	1.65	0.66	0.66	0.00	0.33	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.96	1.49	2.11	0.74	0.74	0.37	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.77	2.96	1.85	0.74	0.00	0.00	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.19	2.22	0.99	0.99	0.49	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.64	0.96	1.65	0.82	0.27	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.11	5.47	0.96	0.32	0.64	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	0.91	1.52	0.91	0.00	0.00	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	4.06	0.84	2.10	1.12	0.56	0.42	1.68	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	0.36	1.07	0.71	0.71	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	2.42	1.45	0.48	0.48	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.29	1.87	1.24	1.09	0.47	0.00	0.78	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.94	3.58	0.72	0.36	0.00	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.17	1.63	0.33	0.33	0.65	0.33	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	1.88	1.41	0.24	0.24	0.24	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.92	3.96	0.99	0.12	0.37	0.25	1.61	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	0.51	1.02	1.02	0.00	0.26	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.46	1.49	0.90	0.30	0.00	0.30	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	6.80	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	3.84	0.77	2.30	0.00	1.53	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	8.91	0.74	0.00	0.00	0.74	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.35	8.46	0.85	1.69	1.27	0.85	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	4.92	2.81	2.11	2.11	1.41	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	2.80	0.93	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	8.24	0.52	3.61	0.52	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	4.76	2.38	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.64	9.05	1.36	1.13	0.45	0.68	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.52	9.31	1.74	2.62	1.16	1.16	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	4.95	3.15	1.80	0.45	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.52	9.62	0.81	0.68	1.22	0.41	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	14.38	0.51	1.54	1.03	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	8.12	2.47	1.06	0.71	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	6.00	0.00	0.67	0.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	14.26	1.53	3.57	1.53	1.02	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	3.47	3.47	1.07	0.80	0.27	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.24	10.01	2.83	2.27	0.57	0.38	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.77	11.66	1.23	0.61	1.23	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	8.97	3.26	2.45	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.82	8.12	3.33	2.08	0.42	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.58	14.29	0.56	2.24	0.28	0.56	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	7.21	4.12	0.00	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.00	6.97	4.94	1.16	0.58	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	6.58	2.09	0.60	0.30	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	1.66	3.32	3.32	0.00	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.74	11.31	4.24	2.83	0.00	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.08	9.59	1.11	2.21	1.11	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	6.91	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.87	5.76	3.07	1.15	1.15	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	33.97	10.19	0.57	0.57	1.70	1.13	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.05	4.92	4.10	3.28	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.69	9.94	3.16	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	29.44	5.75	1.44	1.44	1.44	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	5.98	2.24	2.24	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.30	10.03	1.11	3.72	2.23	1.49	1.49	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.78	3.45	1.72	2.58	1.29	0.43	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	10.28	4.28	0.00	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.99	5.00	2.00	2.33	1.33	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.98	11.46	3.02	1.81	2.41	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	7.11	2.13	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.69	8.59	3.09	3.09	0.69	0.34	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	6.98	1.07	1.07	0.54	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	8.08	7.41	2.69	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.08	7.78	4.82	0.74	1.11	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	2.33	0.00	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	4.23	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	25.61	7.20	5.60	1.20	1.60	0.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	14.54	1.45	0.73	0.73	1.45	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	13.03	3.07	0.00	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.17	14.31	5.43	2.47	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	5.65	3.76	0.94	1.88	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.63	11.06	1.51	1.01	1.51	0.50	1.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.14	5.86	4.51	1.35	1.35	0.00	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	8.61	1.72	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.94	9.35	3.12	2.67	0.45	0.45	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.98	10.95	2.35	1.56	0.78	0.00	1.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	28.37	9.90	2.64	0.00	0.66	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.91	6.23	2.08	2.08	1.04	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	30.19	10.06	2.19	1.31	0.88	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	12.86	1.68	1.68	0.56	0.00	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.29	5.74	3.09	1.77	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.69	10.03	4.24	1.93	0.00	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	12.15	0.00	1.52	0.51	0.51	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.51	9.13	0.96	0.00	0.48	0.48	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.64	8.75	6.36	2.39	0.80	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.34	10.94	1.82	1.22	0.61	0.00	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	9.68	4.15	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.84	11.02	2.28	3.80	0.38	0.38	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.57	13.94	6.20	1.03	1.03	0.00	0.00	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	1.81	3.63	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.99	8.24	4.75	3.49	1.27	0.63	0.00	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.19	12.79	3.20	1.07	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	4.02	9.19	0.00	0.57	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.74	16.97	4.63	1.03	1.54	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	35.37	11.32	2.83	1.41	0.71	0.71	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	6.24	9.08	1.13	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	31.62	9.15	4.58	2.08	2.50	0.42	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	8.61	2.35	3.13	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.62	3.34	5.85	0.42	0.00	0.00	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.02	9.76	3.25	2.79	0.46	0.93	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	32.11	10.70	4.68	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.92	2.14	9.62	0.00	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.52	12.12	3.64	2.83	1.21	0.81	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.96	8.26	0.00	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	20.45	13.34	8.00	0.00	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	31.91	18.24	5.70	1.71	0.00	0.00	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	20.71	2.30	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.79	10.94	9.85	1.64	0.00	0.00	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	22.27	7.57	3.56	0.45	0.45	0.45	0.00	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.17	12.48	0.26	0.78	1.04	0.26	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.93	4.64	4.64	1.33	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	12.47	2.08	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	10.71	1.82	0.46	0.23	0.46	0.91	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	15.97	5.69	0.92	0.92	0.73	1.28	0.18	0.55
Macrophage - monocyte derived, donor3	11389-118C3	8.78	2.36	0.39	0.52	0.13	1.31	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	2.66	0.53	0.00	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	14.10	9.98	0.32	0.32	0.79	0.79	0.63	0.63
Mallassez-derived cells, donor3	11930-125I4	12.79	7.37	0.42	0.14	0.28	0.28	0.83	0.28
Mammary Epithelial Cell, donor1	11273-116H4	7.37	6.78	0.50	0.40	0.60	0.30	0.60	0.20
Mammary Epithelial Cell, donor2	11350-117G9	7.24	5.21	0.29	0.58	0.58	0.29	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	3.24	1.75	0.50	0.00	0.00	0.00	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	0.68	0.00	0.00	0.68	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	0.00	0.00	0.00	0.11	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	3.57	0.30	0.00	0.30	0.30	0.59	0.30	0.00
Mast cell, donor3	11566-120D9	4.05	0.45	0.68	0.68	0.45	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	1.77	0.71	0.18	0.35	0.00	0.53	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	9.35	4.38	1.29	0.90	0.30	0.70	0.80	0.50
Melanocyte - dark, donor2	11582-120F7	18.00	3.46	1.04	1.73	1.04	0.35	0.35	1.38
Melanocyte - dark, donor3	11663-122F7	4.27	3.40	1.67	0.72	0.51	0.43	0.29	0.07
Melanocyte - light, donor1	11274-116H5	8.93	5.88	0.71	0.24	0.47	0.94	0.47	0.47
Melanocyte - light, donor2	11351-117H1	3.41	4.78	0.00	0.00	0.00	0.00	2.73	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.87	2.60	0.00	0.87	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.31	4.58	1.25	0.52	0.10	0.62	0.42	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	8.07	5.65	1.08	0.27	1.08	0.27	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	7.77	6.43	0.54	0.54	1.34	0.54	0.80	0.27
Meningeal Cells, donor1	11493-119E8	27.91	12.03	15.14	0.25	1.12	1.12	0.74	0.74
Meningeal Cells, donor2	11573-120E7	6.16	1.32	4.40	0.00	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	17.03	11.17	1.06	1.63	1.14	0.65	0.49	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.41	2.85	0.86	1.14	1.14	0.57	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.49	2.62	0.81	0.50	0.20	1.21	1.01	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	35.48	10.51	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	13.08	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	6.46	4.31	0.72	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	33.46	7.84	1.91	1.69	1.06	0.64	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	28.15	10.05	2.01	2.51	1.01	0.50	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.89	5.05	1.32	0.00	0.44	0.22	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	3.65	0.00	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	5.12	0.61	0.41	0.20	0.00	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.93	0.42	4.43	0.00	0.14	0.42	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.16	0.00	0.74	0.37	0.00	0.74	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.92	3.95	1.45	1.84	0.26	0.92	0.79	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	47.18	3.86	1.48	0.89	0.00	0.59	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	4.67	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	8.33	2.56	0.00	1.28	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.28	6.03	0.00	1.77	0.71	1.06	0.71	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.95	3.75	0.31	2.50	0.31	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.08	2.18	1.45	0.00	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	23.60	4.51	1.59	1.33	0.80	0.53	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	17.02	3.50	1.50	0.00	0.00	1.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	18.07	2.96	1.37	1.81	0.36	0.58	0.79	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	8.10	0.00	0.00	2.70	2.70	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.05	0.49	3.69	0.74	0.49	0.99	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	1.18	0.88	0.59	0.29	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.37	0.62	0.62	0.00	0.31	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.88	1.87	1.04	0.62	0.62	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	4.63	0.00	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.01	1.25	3.00	1.25	0.50	0.75	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.17	2.79	0.47	0.00	0.00	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.18	0.81	2.03	0.61	0.61	0.41	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.30	1.58	0.79	0.79	1.58	0.79	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	1.77	5.31	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	2.66	1.52	0.76	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.49	1.27	1.27	1.27	0.21	0.64	1.06	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	3.68	0.00	0.00	0.00	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.92	2.98	1.19	1.49	0.30	0.60	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.29	1.25	1.00	1.25	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.83	1.90	0.48	0.24	0.48	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	0.00	0.00	0.00	0.55	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.20	2.76	0.92	0.69	0.46	0.69	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.99	1.89	2.31	0.42	0.84	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.64	2.24	0.41	0.82	0.20	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.37	2.79	0.43	1.29	0.21	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.78	3.11	0.89	0.67	0.22	0.67	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	0.88	0.66	0.22	0.44	0.88	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	2.53	1.01	0.00	0.51	0.51	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.61	0.54	0.27	0.27	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	1.47	0.59	0.29	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	1.09	1.09	0.00	1.09	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	0.96	0.00	0.00	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.01	2.00	1.20	0.80	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	2.74	1.37	1.37	0.00	2.74	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.50	2.00	0.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	0.44	0.44	0.00	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	4.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	0.64	0.00	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	1.49	0.00	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	2.09	0.70	0.70	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.79	0.68	0.00	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	0.44	0.00	0.44	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	0.71	0.00	0.00	0.71	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.37	0.28	0.28	1.12	0.56	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	2.49	0.42	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	0.58	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.02	0.90	0.30	0.00	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.02	1.25	2.09	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	0.00	0.00	0.00	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	1.14	2.28	0.57	0.57	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.22	1.11	0.41	0.00	0.28	0.41	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.44	1.04	0.26	0.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.01	1.29	1.72	0.00	0.43	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	0.00	0.00	0.00	0.00	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.54	0.27	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.35	2.10	2.10	0.90	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	0.42	0.00	0.00	0.28	0.42	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	0.00	0.32	0.00	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.60	1.77	0.44	0.66	0.44	0.88	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.69	0.38	0.38	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.51	1.14	0.00	0.00	0.28	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.32	1.23	1.23	0.00	0.00	0.98	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	2.61	0.00	0.65	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	2.06	0.29	1.18	0.29	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.47	2.59	3.17	0.29	0.29	0.86	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	36.27	4.95	1.24	2.06	0.82	3.30	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.97	0.89	0.60	0.60	0.30	0.89	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.26	2.63	0.66	0.00	0.66	0.33	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	3.16	0.00	0.00	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.66	1.19	0.40	0.20	0.59	0.99	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	3.73	0.00	0.00	0.93	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	3.00	0.38	0.38	0.75	1.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.19	1.86	1.07	0.27	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.66	1.13	0.11	0.11	0.23	0.11	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	2.95	0.00	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.40	2.56	0.00	0.37	0.00	1.83	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	6.22	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	2.67	0.00	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	1.01	1.01	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.12	1.69	0.42	0.84	0.42	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	0.00	2.72	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	0.64	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	6.04	3.02	3.02	4.53	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	137.04	11.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	208.80	26.10	0.00	3.26	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	9.50	0.00	0.00	0.00	0.00	14.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.68	5.39	1.72	0.22	0.86	1.29	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.94	10.97	2.61	0.00	1.05	0.00	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	25.36	8.01	0.67	0.67	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.53	1.67	0.00	0.00	0.42	2.92	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	52.67	13.12	1.52	0.57	1.90	1.33	1.14	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	12.77	0.00	1.60	4.79	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.12	4.08	0.00	0.00	2.04	0.68	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	3.68	1.84	9.19	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	7.95	0.84	0.84	1.26	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.20	4.88	0.93	0.23	1.16	0.93	0.93	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.08	7.84	0.27	0.27	1.08	0.27	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	32.38	7.99	4.84	1.05	1.47	0.21	0.84	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	22.27	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.31	4.47	0.50	0.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.38	6.77	1.08	1.35	0.81	0.00	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.72	4.76	0.23	0.23	0.00	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.78	5.72	0.65	0.49	1.47	0.00	0.33	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.07	9.48	2.73	1.09	2.73	0.36	0.55	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	33.42	7.96	0.53	0.53	1.06	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	38.42	6.00	1.80	0.60	3.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	96.48	18.05	0.98	3.61	3.61	0.98	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.65	3.42	0.33	0.16	1.30	0.16	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.27	12.88	6.35	2.12	1.23	1.23	0.71	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	4.22	0.70	0.70	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.59	5.06	0.00	0.92	3.22	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	34.38	7.07	1.29	0.64	0.96	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	64.49	12.07	3.79	0.69	2.76	0.34	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	68.27	17.70	5.06	5.06	5.06	15.17	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.24	10.47	6.02	2.01	2.23	0.22	0.45	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.91	5.93	0.42	1.27	2.12	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	52.69	8.31	0.47	0.24	1.66	0.00	0.95	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.75	6.01	0.86	0.86	0.00	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	9.03	27.08	18.06	27.08	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.66	4.67	1.67	0.00	0.67	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	42.38	10.37	1.80	1.35	0.45	0.45	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	24.60	8.33	0.40	0.40	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	44.57	11.14	0.00	0.93	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	53.35	10.22	1.51	0.00	4.16	0.00	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	35.20	7.82	0.98	0.98	1.30	0.65	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	71.03	8.28	2.61	0.87	2.18	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	52.92	21.71	4.52	3.62	1.81	1.81	0.45	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	43.21	14.99	0.00	0.88	2.65	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	44.54	9.97	0.00	0.66	1.33	0.66	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.57	9.42	0.50	0.99	1.49	0.00	0.50	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	65.85	11.87	1.53	0.38	0.77	0.00	0.38	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	50.51	11.19	1.51	1.21	2.12	0.00	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.33	12.16	5.75	1.55	1.33	0.22	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	43.37	19.65	0.00	0.00	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	0.00	0.00	15.33	5.11	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	48.77	7.93	1.22	0.00	1.83	0.00	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	62.32	7.24	1.26	1.26	1.26	0.31	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.66	8.17	1.51	1.51	2.12	0.30	0.91	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	64.87	29.27	0.00	3.16	4.75	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	125.83	30.61	2.27	6.80	7.94	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	5.06	0.00	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.96	2.36	0.25	0.12	0.87	0.25	0.50	0.25
Myoblast, donor2	11322-117D8	9.97	3.07	1.92	1.53	0.00	1.15	0.58	0.19
Myoblast, donor3	11398-118D3	9.75	1.85	1.18	0.34	0.17	0.34	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	28.60	2.46	0.31	1.85	0.62	1.54	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	26.54	2.11	2.11	3.32	0.30	0.60	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	29.26	2.94	0.92	2.94	0.92	1.66	0.00	0.18
Neural stem cells, donor1	11275-116H6	40.65	63.88	3.99	1.45	2.54	4.72	4.36	3.99
Neural stem cells, donor2	11352-117H2	25.03	15.41	1.93	0.00	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	3.41	7.97	0.00	2.28	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	5.06	6.38	0.66	0.22	0.22	0.44	0.22	0.22
Neurons, donor3	11655-122E8	12.33	7.40	0.00	0.00	1.64	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	375.84	2.78	18.56	7.42	6.50	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	258.00	2.90	5.80	11.60	2.90	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	646.27	9.77	19.55	6.11	3.67	7.94	1.22	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	34.55	3.56	1.19	0.95	1.31	0.71	0.47	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	10.74	1.30	0.00	0.33	0.98	0.00	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	6.82	1.00	4.61	0.40	0.00	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	52.72	24.50	4.40	6.47	1.79	0.28	0.00	1.65
Olfactory epithelial cells, donor2	11934-125I8	63.69	32.71	6.37	7.38	2.17	0.72	0.00	0.87
Olfactory epithelial cells, donor3	11935-125I9	53.91	28.04	7.49	8.51	2.84	0.68	0.68	0.79
Olfactory epithelial cells, donor4	11936-126A1	78.50	25.42	8.18	9.06	3.90	0.29	0.29	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	12.64	5.42	1.20	1.20	0.60	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	35.52	8.72	1.06	0.21	1.06	0.21	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	4.57	1.14	1.14	1.14	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	1.24	0.00	0.00	0.62	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	49.45	18.96	3.71	2.35	0.78	0.20	0.59	1.17
Osteoblast, donor2	11354-117H4	21.77	7.73	2.81	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	13.15	3.02	0.36	0.18	0.18	0.36	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.65	6.65	1.01	1.94	1.35	0.84	0.84	0.42
Pericytes, donor1	11491-119E6	15.80	4.56	9.35	0.22	0.45	0.45	0.22	0.33
Pericytes, donor2	11571-120E5	9.05	1.36	4.75	0.45	0.45	0.45	0.45	0.00
Pericytes, donor3	11652-122E5	14.85	3.66	1.42	2.24	0.41	0.81	1.83	0.20
Perineurial Cells, donor1	11499-119F5	13.22	2.37	1.92	0.57	0.23	0.23	0.34	0.11
Perineurial Cells, donor2	11579-120F4	22.54	6.90	1.66	0.46	0.74	0.64	0.64	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	95.62	19.76	5.74	3.19	3.19	0.64	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	106.52	15.67	8.33	11.26	3.92	1.96	0.24	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	68.98	9.58	1.04	3.36	1.68	1.68	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	5.02	0.72	0.24	0.00	0.00	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	8.87	1.11	1.11	0.00	0.00	0.00	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.82	0.98	0.59	0.59	0.00	0.79	1.37	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.95	6.65	2.22	1.58	1.27	0.63	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	41.64	10.88	3.38	0.75	0.75	1.31	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	112.51	33.81	16.05	9.14	2.87	0.91	0.26	1.57
Preadipocyte - breast, donor2	11328-117E5	24.77	7.20	8.11	2.70	0.90	0.45	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	41.13	6.71	1.70	1.39	0.75	1.49	0.53	0.75
Preadipocyte - omental, donor2	11329-117E6	64.60	22.26	2.18	2.62	1.31	0.00	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	22.92	4.44	0.43	1.58	0.86	2.15	1.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	16.73	0.00	3.94	2.95	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.20	6.45	3.38	0.31	0.61	0.92	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	10.62	3.19	3.01	2.66	0.18	0.89	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	8.17	1.36	1.19	0.34	0.00	0.85	0.85	0.34
Preadipocyte - visceral, donor1	11280-116I2	24.22	8.29	2.70	1.96	0.19	0.84	1.49	0.47
Preadipocyte - visceral, donor2	11357-117H7	17.03	5.52	1.84	1.84	0.92	1.38	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	13.06	2.30	5.43	1.04	0.00	0.21	0.84	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.21	23.38	2.26	1.96	1.66	1.36	1.21	1.06
Prostate Epithelial Cells, donor2	11331-117E8	4.47	1.08	2.17	0.54	0.41	0.14	0.54	0.00
Prostate Epithelial Cells, donor3	11404-118D9	6.80	1.04	0.06	0.43	0.37	0.31	0.55	0.06
Prostate Stromal Cells, donor1	11254-116F3	12.76	3.76	0.23	0.68	0.80	0.91	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	13.27	3.23	2.87	1.97	0.72	0.90	1.43	0.00
Prostate Stromal Cells, donor3	11405-118E1	13.14	2.92	0.21	0.83	0.63	0.63	0.52	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.15	5.11	1.82	0.36	0.00	0.00	1.46	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.66	1.80	0.62	0.62	0.21	0.35	0.49	0.00
Renal Epithelial Cells, donor1	11517-119H5	23.33	4.06	1.52	0.00	2.03	1.01	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	21.34	6.40	0.00	0.00	0.71	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.72	5.50	1.16	0.74	0.74	0.95	0.42	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	2.72	4.09	0.68	0.00	0.00	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.34	1.89	5.79	1.08	0.27	0.27	0.94	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	18.20	5.33	2.44	1.11	0.44	1.11	1.11	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	4.66	2.66	0.00	1.33	0.00	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.33	6.38	1.10	0.66	0.44	0.22	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	21.32	6.90	0.63	3.76	1.25	1.88	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	9.99	1.11	1.11	0.28	0.00	0.83	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.45	6.44	2.15	0.00	1.07	0.54	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.18	3.80	0.00	0.42	0.42	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.85	6.17	1.35	1.93	0.77	0.39	1.54	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	4.67	0.52	1.56	1.04	0.78	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.33	9.66	0.85	0.57	1.42	0.57	1.99	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	18.52	4.12	0.00	0.00	1.03	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	32.37	10.29	1.25	2.01	1.76	0.25	1.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	71.23	24.32	2.67	2.00	1.47	0.80	0.94	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	85.77	30.38	0.00	5.36	0.89	0.00	0.00	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	181.07	62.74	1.10	4.95	7.15	1.10	0.00	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	197.22	66.71	0.58	1.74	5.80	0.58	1.74	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.98	14.56	16.64	0.78	0.91	1.04	0.78	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.41	13.21	3.18	1.99	0.79	1.29	0.30	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.68	20.86	2.68	1.78	1.34	0.89	0.56	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.03	7.32	12.65	1.86	0.74	1.12	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.14	15.27	3.61	2.33	1.17	0.58	0.58	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	47.84	33.05	6.70	2.08	3.24	0.92	0.46	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.30	6.43	11.50	1.10	0.55	0.41	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.65	18.30	7.26	2.27	1.51	0.61	0.45	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	34.05	21.32	2.87	3.05	1.61	0.54	0.54	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.36	5.59	12.19	0.86	0.29	0.72	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.08	17.38	3.76	3.11	0.64	1.07	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.19	25.89	5.31	3.98	2.43	1.33	0.44	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.28	6.12	12.24	0.57	0.76	0.76	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	30.28	18.73	4.19	2.24	1.96	1.02	0.75	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	59.57	37.39	3.01	3.19	1.32	1.13	0.75	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.48	7.03	11.94	0.53	0.93	1.06	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.29	20.73	4.09	2.43	1.56	1.56	1.17	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	33.42	21.01	4.58	2.86	1.15	0.57	0.76	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.26	8.54	8.86	0.53	0.64	1.28	1.28	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.07	17.94	5.05	1.96	0.84	1.96	0.28	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.93	13.50	7.69	2.73	0.85	0.68	0.51	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.25	3.65	8.39	0.55	1.28	1.09	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.84	15.57	3.92	2.82	1.23	1.35	1.47	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.85	11.42	3.90	2.01	1.21	0.54	1.07	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.39	4.72	13.68	0.47	0.71	1.65	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.77	17.26	3.17	2.38	1.19	0.79	1.39	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.97	18.94	7.25	0.70	1.64	2.10	1.17	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.97	2.70	6.84	0.62	0.62	0.41	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.75	20.13	3.98	0.66	1.77	1.33	1.77	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.41	10.44	1.67	2.30	1.04	0.63	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.88	3.50	8.48	0.94	0.27	1.21	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.97	15.16	3.58	1.36	1.19	2.55	0.85	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	35.86	12.15	4.05	3.47	2.31	1.35	1.54	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.65	4.30	7.91	0.69	0.17	1.03	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.95	11.66	2.47	1.23	1.37	1.10	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.33	21.01	4.43	2.13	1.81	1.31	0.33	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.13	6.31	14.15	1.02	0.51	1.53	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.27	16.28	3.26	1.78	1.04	2.22	0.30	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	47.18	24.52	3.47	1.87	2.13	0.80	2.13	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	38.30	7.74	24.06	2.07	0.28	0.69	0.28	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	29.05	14.05	5.95	2.62	1.67	1.67	1.19	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	87.87	45.75	7.86	5.04	4.64	2.02	0.40	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.31	9.04	18.08	1.70	0.28	0.94	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	52.06	23.41	10.48	3.84	3.84	0.35	1.05	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.51	23.27	6.95	3.63	2.12	1.51	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.72	5.51	17.13	0.73	0.73	0.86	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	130.12	51.96	9.17	5.97	4.66	2.91	2.04	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	66.93	27.99	4.26	4.26	3.65	1.83	1.83	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.62	7.84	16.88	0.00	0.60	1.21	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.27	15.38	7.01	3.85	0.68	1.58	0.68	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.89	18.57	4.79	7.19	3.59	0.60	0.60	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.06	12.99	20.43	0.83	1.06	1.42	1.18	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	52.93	13.66	5.34	3.63	2.13	1.92	0.64	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	74.52	17.43	3.00	2.40	2.40	3.61	0.60	0.60
Schwann Cells, donor1	11498-119F4	4.51	1.32	2.82	0.38	0.38	0.38	0.38	0.19
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.86	3.07	1.10	1.10	0.00	0.66	0.00	0.00
Sebocyte, donor1	11220-116B5	18.08	14.79	1.64	0.55	0.55	2.74	1.10	0.55
Sebocyte, donor2	11301-117B5	7.81	4.14	0.92	0.46	0.46	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	8.66	2.89	0.41	0.00	0.21	0.41	0.41	0.00
Sertoli Cells, donor1	11255-116F4	21.54	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	5.65	0.00	2.82	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	43.11	14.69	2.82	2.11	1.32	0.62	0.70	0.62
Skeletal Muscle Cells, donor2	11358-117H8	11.57	2.89	0.72	1.45	0.72	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	17.56	4.18	5.02	1.67	2.51	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.79	6.60	11.62	2.51	1.41	0.63	0.16	0.63
Skeletal Muscle Cells, donor5	11455-119A6	16.20	6.39	11.00	2.08	0.89	0.30	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	11.23	4.92	7.85	0.62	0.15	0.15	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	58.21	28.35	2.39	1.89	3.02	0.50	0.76	2.14
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.12	9.85	3.00	3.42	1.00	0.00	0.43	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	18.75	7.84	1.88	0.79	0.99	0.30	0.40	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.83	23.51	4.13	3.62	2.19	1.26	0.34	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	4.34	1.45	2.17	0.72	0.00	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.03	4.54	8.39	1.24	0.83	0.14	0.14	0.14
Skin - palm, donor1	10286-104F7	112.82	48.35	2.69	2.69	5.37	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.02	0.86	0.00	0.29	0.29	0.29	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	59.71	16.36	0.82	0.82	3.27	2.45	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	3.51	1.17	0.13	0.13	0.26	0.26	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	5.42	2.78	0.28	0.14	0.42	0.42	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	4.78	2.11	0.84	0.56	0.14	0.98	0.84	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	25.16	20.51	5.29	2.54	1.27	3.17	2.96	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	5.40	2.17	0.15	0.60	0.15	0.67	1.35	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.25	0.31	3.09	0.62	0.00	1.23	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.57	2.00	9.78	0.44	0.44	1.33	1.11	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	4.70	0.00	0.59	1.76	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	59.00	11.27	1.77	1.10	1.77	0.66	1.55	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	15.36	7.48	0.39	0.79	0.39	0.00	0.79	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	3.86	0.00	0.00	0.00	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	7.01	0.00	4.00	3.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.64	3.33	1.20	0.40	0.67	0.53	1.20	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.42	3.10	1.33	1.77	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	2.69	0.26	0.51	0.13	0.00	0.00	0.64	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.98	7.49	2.60	0.98	0.65	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.72	8.86	0.30	1.18	1.77	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.40	2.42	0.85	0.43	0.43	1.00	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.25	3.90	1.30	0.00	0.00	1.46	1.63	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	10.35	1.22	0.61	0.30	0.00	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	41.17	6.82	2.27	0.76	1.52	0.25	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	0.48	2.86	0.00	0.00	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.79	5.90	0.59	1.62	0.29	0.29	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	25.18	4.09	2.80	1.51	0.86	0.65	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.00	4.62	0.42	1.47	1.36	0.73	0.52	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	18.41	5.88	0.93	0.46	0.62	0.62	1.24	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	0.00	1.08	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.67	2.09	3.29	0.30	0.30	0.60	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.80	12.63	3.07	1.02	1.02	0.34	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	34.71	12.25	2.59	1.88	2.04	0.31	0.39	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.84	0.30	0.20	0.20	0.00	0.60	1.11	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.29	1.37	1.37	1.59	0.46	0.91	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.00	2.42	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.49	9.54	2.38	0.79	0.53	0.79	1.06	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	12.65	2.40	7.46	0.67	0.27	0.53	1.07	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.04	5.89	4.51	3.51	1.63	0.88	1.00	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.60	2.28	0.76	0.25	0.25	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.52	8.59	0.90	1.06	0.75	0.75	0.90	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	0.00	0.00	0.00	2.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	470.37	126.64	36.18	0.00	18.09	19.38	12.92	10.34
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.62	9.30	1.40	1.40	0.93	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	3.53	0.00	0.00	0.00	0.50	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.58	0.31	0.94	0.63	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.73	3.24	0.29	0.29	1.18	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.33	5.41	1.50	1.08	0.75	0.50	0.67	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	4.67	2.34	0.93	1.87	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.07	2.45	0.86	0.29	0.43	0.72	1.01	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.34	7.39	1.02	0.25	0.51	0.25	0.00	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.56	3.57	2.82	0.75	0.38	0.38	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.82	7.69	1.68	1.54	0.42	0.98	0.42	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	13.49	3.35	2.09	0.84	0.67	0.50	0.34	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.95	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.61	3.67	0.24	0.98	0.24	1.22	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.70	0.66	5.74	0.22	0.22	0.44	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.38	4.39	0.88	0.88	0.88	0.29	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.40	9.72	0.78	2.14	1.36	0.19	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.04	3.97	0.26	0.00	0.26	0.53	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.26	9.30	0.74	4.46	0.74	1.12	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.76	1.80	1.08	1.08	0.00	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.83	0.85	0.00	0.00	0.00	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.96	6.30	0.00	1.58	1.58	0.39	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	40.63	9.90	1.02	1.27	3.30	0.76	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	41.13	4.39	0.00	1.20	0.80	0.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	30.10	5.02	0.00	1.67	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	30.71	2.29	0.00	0.46	0.46	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	7.57	0.84	0.67	0.17	0.00	0.34	0.67	0.17
Synoviocyte, donor2	11368-117I9	34.03	8.72	0.50	3.35	1.68	0.34	0.17	0.67
Synoviocyte, donor3	11440-118H9	18.32	1.56	8.49	2.01	0.45	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	17.87	14.29	0.36	0.00	0.36	0.36	2.14	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	0.00	0.00	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.50	9.26	1.16	0.46	0.69	0.93	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	5.45	4.30	0.72	0.36	0.14	0.22	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	5.03	0.00	0.39	0.39	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	1.15	1.72	0.57	0.00	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	64.96	22.39	3.20	2.46	2.09	0.37	0.98	0.74
Urethra, donor2	10319-105A4	116.90	10.79	1.80	1.80	0.00	3.60	3.60	3.60
Urothelial Cells, donor1	11520-119H8	6.64	3.72	0.27	0.00	0.80	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	4.81	1.60	0.80	1.20	0.00	0.80	0.00	0.80
Urothelial Cells, donor3	11681-122H7	5.50	3.67	0.92	0.23	0.23	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	12.71	2.90	0.89	2.01	0.45	0.45	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	22.24	1.78	8.90	0.00	0.00	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	0.00	7.15	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.22	1.37	2.74	2.74	0.00	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	39.94	3.10	1.03	2.41	0.34	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	5.81	3.49	0.00	0.00	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	4.16	7.29	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	5.51	5.51	0.00	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	0.00	0.00	1.83	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	9.38	8.14	0.49	0.74	0.86	1.48	2.10	0.49
Wilms' tumor cell line:HFWT	10597-108E3	29.04	21.12	2.64	0.88	0.88	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	31.00	19.27	2.23	4.19	3.07	1.12	1.40	0.56
achilles tendon, donor2	10292-104G4	82.66	6.20	4.13	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.06	0.00	0.00	0.51	0.00	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	17.88	11.38	0.70	0.93	0.46	1.39	0.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	24.93	6.65	0.71	0.95	0.00	2.97	0.00	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	16.87	11.97	0.82	1.90	1.36	1.63	0.00	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	37.67	14.62	3.37	3.94	0.28	2.81	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	14.38	1.48	1.06	0.63	0.00	1.69	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	3.81	1.63	0.54	0.82	0.00	0.27	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.56	7.93	1.32	0.00	0.88	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	43.10	10.87	1.16	2.72	1.16	1.94	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.31	0.37	0.55	0.37	0.00	0.18	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	3.90	3.90	3.90	3.90	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.08	2.32	1.16	0.46	0.46	2.09	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.28	1.04	0.52	0.52	0.00	1.29	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.34	0.29	0.00	0.00	0.29	1.17	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.20	4.18	1.39	0.00	0.46	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.03	0.00	0.41	0.82	0.00	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.53	0.92	0.00	0.00	0.00	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.85	0.43	0.00	0.00	0.00	0.43	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.73	0.91	0.00	0.00	0.00	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	2.65	1.44	0.48	0.00	0.00	0.24	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.57	0.89	0.45	0.45	0.22	1.56	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	31.59	1.86	1.86	1.86	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.77	0.38	0.75	0.00	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.68	2.62	0.44	0.44	0.44	2.62	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	44.04	48.28	1.18	0.47	4.00	2.35	0.94	1.88
adipose tissue, adult, pool1	10010-101C1	94.78	24.82	5.74	1.71	0.62	1.55	1.24	1.24
adipose, donor1	10184-103D4	73.30	111.42	1.76	20.52	7.62	5.28	1.17	2.35
adipose, donor2	10185-103D5	49.47	134.63	8.11	15.41	7.70	0.81	1.62	11.35
adipose, donor3	10186-103D6	69.71	109.19	12.25	10.62	5.72	1.91	1.09	4.36
adipose, donor4	10187-103D7	331.10	131.75	45.94	13.87	15.60	1.73	0.00	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.77	18.62	1.26	0.79	3.31	0.32	0.79	1.26
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.51	30.73	1.79	1.79	1.43	0.00	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	58.19	15.53	3.48	3.94	1.16	0.46	0.23	0.93
amniotic membrane cells, donor2	12236-129G4	30.77	4.73	4.06	1.01	0.68	0.68	1.01	1.01
amniotic membrane cells, donor3	12237-129G5	8.54	0.29	5.30	0.00	0.00	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	36.76	11.86	0.00	2.37	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	47.45	10.54	4.46	2.64	1.01	1.01	0.61	0.41
amygdala, newborn, donor10223	10360-105E9	30.34	10.01	0.00	1.29	0.32	0.00	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	30.18	7.13	1.27	2.16	0.89	0.38	0.51	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.71	8.35	0.67	1.34	0.67	1.00	1.00	0.33
aorta, adult, pool1	10052-101G7	132.78	13.93	0.59	2.55	2.94	3.53	2.35	1.37
appendix, adult	10189-103D9	93.92	22.90	11.64	5.05	2.33	1.16	1.16	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.86	6.53	1.03	1.72	1.03	0.00	0.69	2.06
artery, adult	10190-103E1	40.76	6.79	4.08	2.72	0.00	4.08	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	45.20	20.57	3.33	2.46	1.74	3.19	1.88	1.45
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.43	5.27	1.11	0.83	0.28	0.83	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.99	24.01	2.78	0.99	1.19	1.79	1.39	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	40.51	22.09	2.51	2.51	1.34	0.33	1.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.80	0.56	0.00	0.00	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	91.69	8.58	1.96	1.96	2.06	2.39	2.39	1.09
blood, adult, pool1	10053-101G8	44.29	2.21	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	12.85	1.71	0.00	0.86	0.86	1.71	0.00
bone marrow, adult	10192-103E3	59.38	22.27	6.75	2.02	1.35	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	43.05	11.28	2.05	5.13	1.03	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	30.85	6.35	2.23	1.56	1.00	1.67	0.33	0.78
brain, fetal, pool1	10085-102B4	21.37	13.36	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	19.82	3.63	0.99	1.32	0.00	0.99	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	65.03	23.59	1.25	1.37	1.37	1.25	0.62	2.37
breast, adult, donor1	10080-102A8	156.58	22.73	1.89	0.63	3.16	2.53	3.79	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.96	24.90	0.25	1.40	1.14	1.02	1.65	2.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	31.54	22.26	1.55	2.78	2.16	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.42	2.30	1.15	2.30	0.00	1.15	0.69	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	42.37	13.07	4.60	5.57	2.18	0.48	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	2.82	0.47	1.41	0.94	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	66.61	22.09	7.00	2.19	1.42	1.97	0.44	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	15.21	6.97	1.90	2.54	0.63	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.63	7.99	0.53	0.27	1.33	0.27	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	65.63	5.76	0.00	0.00	5.76	3.45	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	37.82	11.21	1.84	2.18	1.00	0.67	0.50	0.84
caudate nucleus, adult, donor10258	10379-105H1	18.34	10.70	0.76	0.76	0.00	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	63.72	24.17	0.73	1.83	1.46	0.37	0.73	3.30
cerebellum - adult, donor10196	10173-103C2	46.61	11.65	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	38.00	3.63	3.84	2.14	0.00	0.21	0.21	0.00
cerebellum, adult, pool1	10083-102B2	16.21	3.10	0.34	1.03	0.34	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	95.48	15.78	0.83	2.49	6.64	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	17.65	5.80	1.76	2.27	1.01	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	46.78	5.85	2.19	0.73	0.73	1.46	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	32.49	15.24	2.44	1.15	0.86	1.15	1.29	0.72
cervical cancer cell line:ME-180	10553-107I4	36.29	9.61	2.82	1.66	0.17	1.16	0.66	0.50
cervix, adult, pool1	10013-101C4	150.45	16.17	6.72	5.88	3.04	2.41	2.73	2.20
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.85	11.57	1.53	1.25	0.98	0.14	0.14	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	18.29	0.00	0.00	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	131.98	107.75	6.71	10.69	5.10	2.36	0.37	4.10
choriocarcinoma cell line:SCH	10785-110H2	115.20	72.94	5.17	8.62	4.19	2.96	1.23	1.97
choriocarcinoma cell line:T3M-3	10618-108G6	260.66	110.53	25.38	17.31	9.49	6.64	0.47	7.59
chorionic membrane cells, donor1	12238-129G6	152.15	41.88	13.68	11.68	3.13	3.70	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	29.63	13.42	2.98	3.08	1.09	0.89	0.80	0.20
chorionic membrane cells, donor3	12240-129G8	106.60	28.02	86.82	11.54	1.65	3.30	2.20	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	2.02	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.56	5.96	0.19	1.54	0.58	0.96	0.58	1.73
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.80	0.26	0.00	0.26	0.00	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.18	0.48	0.24	0.24	0.00	0.48	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.24	1.02	0.20	0.20	0.41	0.41	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	5.01	7.36	0.59	0.59	0.00	0.29	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	12.77	3.91	1.30	1.04	0.52	1.82	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	7.09	7.77	1.37	1.37	0.46	0.69	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	39.39	7.63	1.39	1.21	0.69	1.39	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	42.47	36.06	4.76	2.01	1.46	0.73	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	61.19	82.10	0.38	2.66	4.18	0.76	0.38	9.50
colon, adult, donor1	10082-102B1	168.98	35.70	11.90	8.33	3.57	2.38	1.19	3.57
colon, adult, pool1	10014-101C5	166.27	32.90	6.82	4.94	3.53	2.00	1.06	2.94
colon, fetal, donor1	10070-101I7	391.80	62.42	12.98	15.45	17.92	0.62	1.24	3.71
common myeloid progenitor CMP, donor1	12130-128D6	36.67	9.17	0.00	0.00	0.00	18.33	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	27.20	4.25	2.12	1.27	1.70	0.42	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.04	2.87	0.30	0.60	0.45	0.30	0.15	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	17.20	5.08	0.56	0.71	0.14	0.71	0.14	0.99
corpus callosum, adult, pool1	10042-101F6	65.67	13.60	4.75	2.10	0.55	1.55	1.11	1.55
cruciate ligament, donor2	10295-104G7	148.32	32.42	6.48	3.24	2.43	3.24	1.62	7.29
diaphragm, fetal, donor1	10069-101I6	114.77	10.43	3.21	3.21	1.61	0.00	0.00	0.80
diencephalon, adult	10193-103E4	32.64	13.44	1.92	2.64	1.68	1.20	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.36	21.03	2.31	0.26	1.80	2.82	1.03	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.89	13.00	1.93	0.96	1.93	0.48	0.72	0.00
ductus deferens, adult	10196-103E7	101.16	32.89	8.97	10.47	1.99	4.49	3.49	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	265.00	37.45	4.32	8.64	10.08	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	180.23	33.84	12.51	1.47	5.15	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	60.37	38.32	4.96	2.06	3.39	4.13	2.40	2.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.32	7.33	1.55	1.55	0.22	0.22	3.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.09	25.22	1.86	2.15	0.57	1.15	1.58	2.01
embryonic pancreas cell line:1B2C6	10604-108F1	59.20	15.42	3.08	1.23	0.00	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	33.60	13.32	0.61	0.61	0.30	0.00	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	72.56	24.70	1.54	0.62	0.93	0.62	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	70.93	26.27	2.63	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	43.91	11.40	2.01	2.35	1.01	0.67	4.02	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	55.64	11.78	0.91	3.26	1.09	1.09	2.17	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.41	3.38	1.13	1.29	0.16	1.61	0.48	0.32
epidermoid carcinoma cell line:A431	10426-106D3	59.03	32.46	2.11	3.11	3.22	1.22	0.89	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	16.50	7.37	2.31	0.55	1.21	0.66	1.43	0.44
epididymis, adult	10197-103E8	52.96	15.49	3.77	5.02	2.09	1.47	2.72	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.93	18.63	1.60	1.60	2.66	1.06	2.13	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	4.72	1.18	0.39	0.00	0.00	0.00	2.36	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.59	16.12	2.10	2.75	1.18	1.31	1.97	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	19.88	20.96	2.46	2.66	1.57	2.07	1.67	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.32	14.34	1.34	2.46	1.23	2.02	1.79	1.12
esophagus, adult, pool1	10015-101C6	47.99	11.04	1.91	1.17	1.17	1.59	1.38	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	92.30	11.52	2.38	1.63	1.88	2.63	2.76	0.88
eye - muscle inferior rectus, donor1	10272-104E2	115.90	26.56	2.41	0.00	2.41	2.41	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	67.33	18.94	2.10	2.10	2.10	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	61.02	14.88	1.49	4.46	0.00	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	103.18	24.08	8.03	0.00	2.29	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	23.32	8.74	4.37	0.00	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	60.25	11.44	2.29	2.54	1.78	0.76	1.27	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	21.80	18.21	0.51	1.15	1.92	0.90	0.64	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	28.02	12.11	3.56	1.19	1.42	0.95	1.66	0.47
frontal lobe, adult, pool1	10040-101F4	34.43	8.91	3.00	1.50	0.75	1.50	0.28	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.12	20.72	0.90	3.00	0.60	0.60	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	21.76	9.69	0.55	0.27	0.82	1.01	1.55	0.64
gall bladder, adult	10198-103E9	55.05	19.31	5.31	1.45	1.45	2.41	1.45	0.97
gamma delta positive T cells, donor1	11937-126A2	9.13	1.07	1.07	1.07	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	37.35	8.96	3.36	1.87	0.37	0.75	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.97	2.32	0.63	0.42	0.21	0.42	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	43.91	37.72	7.16	4.06	0.97	6.96	10.25	2.32
gastric cancer cell line:AZ521	10549-107H9	83.29	61.81	13.12	5.25	4.59	9.67	5.41	1.64
gastric cancer cell line:GSS	10560-108A2	30.20	6.41	0.92	0.92	0.00	0.00	0.00	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	110.12	48.43	5.03	3.66	6.17	1.83	1.14	1.83
giant cell carcinoma cell line:LU65	10487-107B1	13.42	5.74	1.49	0.80	0.57	0.11	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	24.63	14.14	1.40	0.56	1.26	0.98	0.98	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	38.16	13.22	2.49	2.49	1.00	2.49	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.05	14.04	1.58	0.95	1.06	0.74	1.37	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.75	14.18	1.26	1.54	2.95	1.12	1.40	0.70
glioblastoma cell line:T98G	10485-107A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	51.25	14.64	1.46	0.88	0.59	0.59	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	61.96	8.75	1.46	2.19	1.46	0.73	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	48.33	4.64	1.95	4.39	1.22	0.98	1.22	1.22
globus pallidus, adult, donor10258	10367-105F7	24.65	4.11	2.74	5.48	2.74	1.37	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	65.55	15.45	1.60	2.13	1.07	0.00	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	44.05	7.34	2.45	2.45	2.45	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	49.60	13.44	1.60	0.96	0.96	1.28	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	104.68	84.94	2.30	0.00	3.67	1.38	0.46	4.13
hIPS +CCl2, biol_rep2	14384-156C1	89.62	64.02	5.03	0.00	5.03	0.91	0.00	3.20
hIPS +CCl2, biol_rep3	14385-156C2	98.55	74.07	2.58	0.00	2.58	0.00	0.00	2.58
hIPS, biol_rep1	14380-156B6	56.05	73.30	0.00	0.00	5.75	0.00	0.00	2.87
hIPS, biol_rep2	14381-156B7	78.19	70.64	3.43	0.00	3.43	0.00	0.69	4.12
hIPS, biol_rep3	14382-156B8	77.24	17.66	1.10	0.00	2.21	4.41	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	14.94	3.45	1.44	2.01	0.29	0.29	0.29	0.29
heart - mitral valve, adult	10205-103F7	69.06	9.57	5.68	2.99	1.79	2.09	2.99	0.30
heart - pulmonic valve, adult	10206-103F8	62.75	9.94	3.92	2.09	0.78	3.14	5.23	1.05
heart - tricuspid valve, adult	10207-103F9	42.46	0.83	5.00	2.50	1.67	0.83	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	33.47	6.33	0.00	1.22	1.02	0.82	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	45.14	5.96	0.43	1.70	0.85	1.70	1.28	0.43
heart, adult, pool1	10016-101C7	25.30	2.76	0.46	0.92	0.46	2.30	1.38	0.46
heart, fetal, pool1	10046-101G1	81.84	10.47	4.21	1.44	1.54	2.88	3.59	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	46.90	6.48	0.00	0.93	1.23	0.62	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	72.54	78.49	4.76	5.95	7.14	2.38	2.38	7.14
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.95	35.36	4.97	4.75	1.88	0.99	0.77	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.64	32.04	4.85	4.01	1.94	0.97	1.09	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.74	43.55	5.56	5.05	3.64	1.11	1.01	1.82
hepatoma cell line:Li-7	10484-107A7	30.36	29.14	3.23	2.67	1.11	2.78	1.78	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2.01	1.11	0.00	0.30	0.10	0.20	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	57.73	5.68	1.89	2.84	0.00	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	51.64	9.59	5.10	3.88	0.82	0.82	1.22	0.20
hippocampus, adult, donor10258	10374-105G5	29.88	7.97	0.00	0.00	0.50	2.49	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	20.09	8.46	1.06	2.47	0.00	0.00	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	177.00	158.08	4.88	14.65	12.82	6.10	1.22	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	66.17	54.00	10.21	11.58	4.71	0.79	0.20	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	102.32	75.66	2.79	14.22	8.63	1.02	0.00	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	65.41	89.09	3.38	5.64	6.20	1.13	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	52.68	115.16	14.20	13.94	5.42	2.32	0.26	6.97
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	53.52	75.92	3.04	6.07	4.56	1.14	0.76	6.83
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.47	129.92	2.92	5.84	3.21	4.38	1.75	7.01
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.41	102.33	11.85	16.16	3.23	2.80	1.08	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	112.61	1.25	5.84	8.34	4.17	1.25	7.51
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.60	45.94	7.10	4.26	0.24	3.32	0.71	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.93	91.29	13.66	13.66	4.34	2.73	0.64	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	81.47	6.73	4.04	2.02	2.69	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	60.09	51.64	9.86	12.52	4.54	1.10	0.16	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	85.49	88.92	20.63	16.21	7.86	1.47	0.00	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	157.10	144.88	2.62	15.71	13.09	0.00	0.00	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.91	69.68	9.16	10.31	3.25	1.53	1.15	4.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.89	61.92	10.90	7.41	3.05	1.31	1.31	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	68.47	146.93	1.50	9.50	7.00	1.50	1.50	6.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.24	92.12	13.00	11.12	4.14	2.64	0.94	5.65
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	36.83	97.76	27.74	9.09	5.46	1.82	0.91	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	61.39	118.40	2.51	8.46	6.26	0.31	0.00	10.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	15.68	57.32	8.49	9.14	2.29	0.65	0.82	4.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.35	41.22	9.58	6.10	2.90	0.87	0.29	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	28.10	88.18	2.09	4.18	4.78	2.09	0.60	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	83.50	103.46	17.74	23.83	7.39	0.74	0.37	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	88.72	91.29	29.38	16.55	5.99	1.43	0.29	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	164.14	167.82	6.53	22.46	13.47	1.22	0.00	6.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	40.84	92.60	21.12	6.34	4.93	1.76	0.70	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.01	59.86	13.62	7.60	2.22	0.63	0.63	3.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	76.87	2.12	6.36	3.33	0.61	0.91	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	14.48	51.71	8.79	5.69	1.03	1.03	1.03	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	26.57	76.38	9.96	5.98	2.66	2.66	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.42	48.74	1.28	5.64	1.28	1.28	0.26	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.15	34.26	12.02	3.83	2.56	2.05	0.51	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	51.49	9.84	3.79	2.27	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	30.25	67.88	2.35	2.69	3.02	0.34	0.67	4.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	85.49	95.88	34.78	13.28	6.04	1.45	0.72	4.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	143.95	160.88	3.57	20.05	11.14	0.89	0.45	7.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	139.51	162.44	4.39	14.63	9.76	1.46	0.00	5.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.37	57.46	15.28	7.64	3.06	0.61	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	178.93	279.78	22.77	45.55	16.27	19.52	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	68.51	139.33	1.99	8.60	10.59	2.32	0.33	5.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.57	91.95	19.16	6.57	4.93	2.19	2.19	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.87	115.08	2.53	10.49	5.43	2.53	0.72	4.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.79	111.39	1.42	7.83	4.63	3.56	0.00	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	44.16	7.16	2.39	3.58	1.19	0.00	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.22	75.30	11.38	3.79	2.30	2.30	0.81	3.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	28.29	73.81	1.89	5.93	2.69	1.35	0.81	2.16
immature langerhans cells, donor1	11904-125F5	12.35	1.94	0.00	0.00	0.24	0.48	0.24	0.00
immature langerhans cells, donor2	11905-125F6	30.10	4.75	1.58	0.79	2.38	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	40.50	13.25	2.93	1.61	1.14	1.32	0.57	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	22.44	3.25	0.98	0.98	0.00	0.65	0.65	0.00
kidney, adult, pool1	10017-101C8	37.65	8.51	1.50	1.30	0.50	2.10	1.70	1.00
kidney, fetal, pool1	10045-101F9	129.09	13.51	5.02	1.63	2.48	3.82	2.41	1.49
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.10	17.47	1.42	1.70	1.85	5.25	2.70	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.28	9.12	1.38	1.24	0.55	0.28	0.28	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.82	5.14	1.83	0.55	0.18	1.65	1.65	0.00
left atrium, adult, donor1	10079-102A7	59.93	7.08	1.09	2.18	3.27	2.18	0.54	0.00
left ventricle, adult, donor1	10078-102A6	27.81	2.53	0.00	0.51	1.52	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	98.50	63.20	2.46	3.01	2.46	0.82	0.00	2.19
leiomyoma cell line:10964C	10569-108B2	5.39	1.08	0.00	1.08	0.36	0.36	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	4.89	0.00	0.00	0.54	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	8.50	1.70	0.49	0.49	0.24	0.24	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	13.59	1.05	0.00	0.00	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.21	7.67	0.24	0.59	0.47	0.47	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	17.03	6.87	0.31	0.62	0.47	0.31	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	13.04	6.09	0.49	0.24	0.49	0.61	0.73	0.12
liver, adult, pool1	10018-101C9	61.75	30.95	2.59	2.76	2.27	0.49	0.65	1.13
liver, fetal, pool1	10086-102B5	38.57	20.70	0.94	1.88	2.82	0.00	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	58.04	6.42	3.79	3.35	1.31	0.73	0.87	0.15
locus coeruleus, adult, donor10252	10165-103B3	41.89	5.54	4.24	2.40	0.92	1.85	0.74	0.18
locus coeruleus, adult, donor10258	10375-105G6	33.57	7.90	0.85	0.56	1.69	0.28	0.00	1.41
locus coeruleus, newborn, donor10223	10362-105F2	237.23	99.27	5.05	9.25	5.89	4.21	0.42	3.79
lung adenocarcinoma cell line:A549	10499-107C4	35.71	17.58	2.63	3.18	1.25	0.97	1.25	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	15.17	2.07	1.38	1.38	2.07	2.07	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.41	11.47	2.50	0.92	0.92	1.05	1.98	0.53
lung, adult, pool1	10019-101D1	70.52	15.47	3.07	2.13	1.54	0.95	0.95	1.77
lung, fetal, donor1	10068-101I5	192.08	13.41	57.08	0.57	1.43	6.56	2.57	2.00
lung, right lower lobe, adult, donor1	10075-102A3	122.80	34.37	7.79	8.25	7.33	2.29	0.46	2.75
lymph node, adult, donor1	10077-102A5	47.34	11.36	0.00	2.37	2.37	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	97.69	46.72	1.70	2.55	0.85	3.40	1.70	3.40
mature adipocyte, donor1	12231-129F8	113.22	70.15	2.22	1.78	3.11	0.44	1.78	1.78
mature adipocyte, donor2	12232-129F9	145.89	62.88	3.32	3.11	4.57	0.62	1.66	2.28
mature adipocyte, donor3	12233-129G1	104.78	49.78	4.27	3.32	2.84	1.66	0.00	2.13
mature adipocyte, donor4	12234-129G2	83.44	57.64	1.58	2.37	2.90	1.05	1.05	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	99.12	77.20	1.43	2.38	3.57	3.10	3.57	5.96
medial frontal gyrus - adult, donor10196	10170-103B8	50.76	10.15	4.51	0.00	0.00	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	56.09	12.32	4.41	2.39	1.29	0.92	0.74	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	38.44	9.53	0.32	1.27	1.27	1.27	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	40.52	16.63	0.43	2.13	1.28	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	57.38	11.14	8.10	3.88	1.35	0.68	0.51	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	49.87	10.19	3.82	2.76	0.21	1.91	0.42	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	3.85	0.00	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	14.35	57.41	86.12	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.97	6.10	0.72	1.08	0.36	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	68.14	7.79	1.95	1.30	2.60	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	43.50	3.10	2.79	2.79	0.46	1.86	1.08	0.77
medulla oblongata, adult, pool1	10038-101F2	40.08	4.90	2.86	0.57	0.98	1.22	0.90	0.82
medulla oblongata, newborn, donor10223	10361-105F1	61.10	9.03	1.04	3.47	0.69	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	52.03	46.94	3.99	3.99	5.31	1.33	0.89	2.21
medulloblastoma cell line:ONS-76	10759-110E3	37.90	14.55	0.61	0.61	1.35	0.86	1.59	0.98
melanoma cell line:COLO 679	10514-107E1	14.09	11.79	1.01	0.43	0.29	0.29	1.15	0.57
melanoma cell line:G-361	10465-106H6	13.57	13.30	1.90	0.81	0.54	0.54	0.54	1.09
meningioma cell line:HKBMM	10691-109F7	20.98	5.61	1.63	1.63	1.63	0.36	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	0.88	0.00	0.00	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.26	0.00	0.26	0.00	0.00	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.81	3.07	9.05	1.23	0.31	0.61	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.18	3.27	7.82	1.27	0.36	0.36	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	2.90	7.04	0.00	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.35	0.42	1.26	0.00	0.00	0.70	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.04	0.39	2.50	0.00	0.00	0.39	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	1.39	3.47	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	0.34	2.92	0.51	0.00	0.51	1.72	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.21	0.69	4.26	1.04	0.00	1.27	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.88	2.79	8.09	0.66	0.27	0.66	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.54	0.68	3.24	0.41	0.14	0.95	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.83	1.42	3.84	0.71	0.14	0.28	1.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	17.46	1.65	0.66	2.63	0.99	1.98	1.98	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	5.40	1.52	5.26	0.28	0.28	0.42	0.97	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.44	4.89	2.79	3.49	0.35	0.70	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.04	0.20	2.04	0.20	0.00	0.00	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.46	6.47	0.72	1.80	0.00	0.72	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.55	0.52	3.31	0.41	0.00	0.41	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.86	1.60	0.23	0.68	0.23	1.37	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	4.62	1.26	4.20	0.00	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	3.59	0.30	2.39	0.45	0.00	1.05	0.75	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.70	1.58	6.39	0.61	0.09	0.35	0.88	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.20	0.74	1.10	0.37	0.00	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.16	4.01	0.57	2.00	0.57	1.43	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	7.16	1.26	0.84	0.42	0.00	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.40	6.85	3.65	1.83	2.28	0.91	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	41.69	7.93	2.56	2.81	1.53	0.51	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	39.79	8.11	2.88	2.09	1.31	0.26	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.36	5.85	2.77	2.46	2.16	0.92	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	43.78	10.12	2.35	3.29	1.65	0.24	0.71	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.01	8.80	3.38	2.03	0.00	1.35	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	35.76	5.89	2.75	4.72	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	9.27	2.32	1.85	1.39	1.39	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	54.80	10.67	1.44	1.73	0.87	0.87	0.87	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	45.29	8.48	2.01	1.78	0.67	0.67	0.45	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	48.55	8.65	2.88	2.16	1.20	0.72	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	73.33	17.60	2.93	3.67	1.47	2.93	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.94	5.37	2.69	1.34	1.01	0.00	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.84	9.42	2.46	2.46	1.23	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.24	5.58	3.01	0.86	0.86	0.00	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	24.61	8.20	8.20	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	43.20	10.07	2.92	3.57	0.65	0.97	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	16.00	4.36	2.91	0.00	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	53.84	17.06	6.93	3.73	1.07	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	47.43	10.63	5.72	4.09	4.09	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.98	15.16	6.22	3.11	2.33	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	16.79	4.20	2.10	4.20	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	42.72	22.85	3.97	0.99	3.97	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	14.30	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.84	13.05	3.56	2.37	1.78	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	49.96	18.28	9.75	4.87	3.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	11.40	8.87	2.53	1.90	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	45.18	17.25	4.48	3.10	2.41	0.34	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	15.04	10.75	2.15	2.15	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	15.97	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	10.33	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	6.93	0.81	1.22	0.41	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	15.89	2.38	1.59	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	30.07	10.61	0.59	2.36	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.02	9.97	0.62	1.87	2.81	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	45.45	12.03	1.34	1.34	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	63.86	20.11	3.55	2.37	3.55	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	20.54	2.57	5.14	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	44.06	13.08	2.07	3.44	2.75	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	47.01	16.33	1.98	2.97	0.99	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	10.09	1.12	2.24	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.98	13.99	1.91	3.18	1.91	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	19.75	9.67	0.40	2.01	2.01	0.00	0.40	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	4.36	2.18	2.18	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	19.01	0.00	3.80	2.53	0.00	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	6.68	4.25	0.61	1.21	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	13.56	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	10.71	0.82	2.47	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	74.21	16.27	5.56	2.58	1.39	0.20	0.00	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	40.56	14.28	1.62	1.95	1.30	0.97	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	59.08	9.17	0.00	2.04	5.09	0.00	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	77.37	25.53	2.32	0.77	3.87	0.77	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.03	9.45	1.42	0.71	1.42	0.94	0.94	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	53.75	42.63	2.55	2.32	2.09	0.93	0.46	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	8.55	12.82	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	29.18	17.47	0.72	0.62	2.06	0.62	0.21	1.23
mesothelioma cell line:Mero-25	10850-111F4	12.48	16.57	1.82	1.13	0.00	0.23	1.59	0.45
mesothelioma cell line:Mero-41	10851-111F5	6.60	7.09	1.22	0.73	0.00	0.73	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	10.63	5.31	1.33	0.89	0.66	0.66	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	23.65	10.51	3.42	2.37	1.05	1.05	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	5.79	5.11	0.85	0.51	0.00	0.34	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	24.01	13.90	4.55	0.51	1.26	0.00	0.51	1.01
mesothelioma cell line:Mero-95	10856-111G1	13.46	3.73	1.24	1.04	0.41	0.83	1.24	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	8.61	2.48	0.83	0.50	0.00	0.66	1.16	0.17
mesothelioma cell line:NCI-H226	10846-111E9	7.42	4.52	0.54	1.45	0.36	0.36	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	52.27	22.38	5.98	2.39	1.54	1.02	1.02	1.20
mesothelioma cell line:NCI-H28	10845-111E8	18.58	9.92	2.04	1.27	1.27	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	8.48	4.24	0.65	0.33	0.33	0.33	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	22.76	7.59	2.17	1.08	1.90	0.54	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	0.77	0.00	0.00	0.00	0.00	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.61	0.00	0.00	0.00	0.00	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	1.08	0.00	0.00	0.00	0.00	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.02	6.20	1.31	3.26	0.65	0.33	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.54	7.21	0.00	1.48	0.64	0.21	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	110.80	46.76	2.99	2.30	3.23	2.99	4.61	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	38.07	23.28	2.22	2.22	0.74	1.11	0.55	1.29
myeloma cell line:PCM6	10474-106I6	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	53.27	20.29	2.03	2.03	2.54	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.85	2.75	1.57	0.59	0.39	1.77	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.13	0.89	1.34	0.33	0.00	0.11	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.41	1.40	0.59	0.59	0.15	0.22	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	46.92	10.49	2.21	1.10	2.21	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.69	0.23	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	82.69	28.62	6.17	2.81	3.37	3.93	1.68	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	5.06	8.86	1.05	0.42	0.21	1.05	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	5.03	0.93	0.37	0.00	0.56	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.18	10.44	0.24	0.95	1.19	0.24	1.90	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	10.14	7.29	0.79	0.79	0.79	0.63	0.16	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	20.93	24.35	1.21	2.21	0.40	0.60	0.60	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	11.44	1.91	0.00	0.00	0.00	0.00	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	55.89	25.02	1.86	1.06	2.13	0.80	1.60	0.80
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.27	35.01	2.71	3.72	2.54	2.37	0.17	4.06
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.40	5.45	1.60	1.60	0.64	0.00	1.28	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.29	4.73	1.31	0.79	0.79	0.79	0.79	0.53
nucleus accumbens, adult, pool1	10037-101F1	38.62	12.94	4.78	1.12	0.94	1.03	0.37	0.84
occipital cortex - adult, donor10196	10172-103C1	90.66	2.06	0.00	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	61.99	7.51	6.44	6.17	0.81	1.88	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	18.56	5.10	0.36	1.09	0.00	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	31.49	7.08	1.05	1.57	0.79	1.05	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	20.17	7.72	0.43	1.72	0.86	0.86	0.86	1.72
occipital pole, adult, pool1	10036-101E9	31.69	6.15	3.55	0.87	0.79	3.07	0.32	0.79
olfactory region, adult	10195-103E6	36.68	7.45	2.67	2.10	0.38	0.38	0.76	0.96
optic nerve, donor1	10277-104E7	50.03	10.01	2.00	4.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.64	11.05	0.57	0.91	0.68	0.46	0.46	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	55.09	16.21	4.26	4.67	1.24	0.41	0.69	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.12	13.04	0.68	0.68	1.19	0.17	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	19.75	12.24	3.93	1.73	0.81	1.73	2.08	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	41.16	10.58	4.12	2.06	1.76	0.29	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	65.40	37.37	5.61	1.87	0.93	2.80	16.82	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	23.11	18.24	1.06	1.48	1.70	0.85	0.85	1.48
ovary, adult, pool1	10020-101D2	79.66	9.26	3.58	2.27	1.40	3.93	3.23	1.48
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.38	2.93	0.00	0.18	0.37	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	38.57	26.34	0.00	1.88	6.58	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.86	50.60	5.59	6.43	1.96	1.12	0.56	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	11.58	6.81	0.17	1.19	0.34	1.02	1.70	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	172.70	48.52	4.80	2.98	4.80	1.32	1.32	2.15
paracentral gyrus, adult, pool1	10035-101E8	26.82	7.14	2.01	0.92	1.01	0.73	0.18	0.82
parietal cortex, adult, donor10258	10373-105G4	97.62	22.02	5.14	0.73	1.47	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	47.96	10.35	1.88	1.88	0.00	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	43.61	4.85	3.99	2.57	0.00	1.71	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	31.02	6.87	2.47	1.06	0.62	0.88	0.53	0.44
parietal lobe, fetal, donor1	10072-101I9	71.77	60.13	5.82	1.94	2.91	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	25.05	11.22	0.37	2.62	1.87	0.00	0.75	0.37
parotid gland, adult	10199-103F1	28.98	1.85	1.23	2.47	0.00	1.23	0.62	0.00
penis, adult	10200-103F2	73.58	14.50	11.82	3.76	3.76	0.54	2.15	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.14	8.37	0.93	0.74	0.74	0.00	0.56	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.21	5.68	0.58	1.02	0.73	0.29	0.87	0.15
pineal gland - adult, donor10196	10179-103C8	84.50	12.26	1.94	1.29	5.81	3.23	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	107.19	9.48	5.33	1.78	2.37	0.00	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	37.00	5.64	0.00	1.25	0.63	1.25	1.25	2.51
pituitary gland - adult, donor10196	10180-103C9	161.89	16.19	2.02	4.05	4.05	2.02	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	169.90	13.03	7.82	2.61	3.65	1.04	2.61	2.08
pituitary gland, adult, donor10258	10378-105G9	48.52	2.55	1.70	0.85	0.85	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	72.67	25.05	2.58	1.61	1.61	0.97	0.75	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	0.13	0.13	0.00	0.00	0.00	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	66.77	19.92	3.89	1.71	1.71	1.56	0.78	1.09
pons, adult, pool1	10033-101E6	19.88	2.93	0.86	0.95	0.34	1.03	0.60	0.34
postcentral gyrus, adult, pool1	10032-101E5	33.48	7.67	2.79	1.48	0.78	1.13	0.17	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	2.09	0.00	4.18	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.62	32.63	1.46	1.75	1.75	1.02	0.87	2.91
prostate cancer cell line:PC-3	10439-106E7	134.13	90.57	5.81	7.44	6.17	0.36	1.45	3.27
prostate, adult, pool1	10022-101D4	67.11	6.62	3.36	1.36	1.27	2.27	1.72	0.91
putamen, adult, donor10196	10176-103C5	38.95	13.93	3.78	4.25	1.42	1.65	0.94	1.18
putamen, adult, donor10252	10152-102I8	43.14	1.96	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	39.34	3.28	3.28	2.19	0.00	1.09	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	13.05	5.80	1.69	0.48	0.24	0.72	0.00	0.00
putamen, newborn, donor10223	10365-105F5	101.95	30.74	1.50	2.25	0.00	4.50	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	92.23	67.50	4.36	2.91	2.33	3.20	4.95	3.20
rectum, fetal, donor1	10067-101I4	242.03	29.21	9.74	18.08	5.56	0.00	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.78	5.94	0.00	0.64	0.64	0.00	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.95	9.53	0.41	2.49	1.24	0.41	0.00	0.83
retina, adult, pool1	10030-101E3	61.63	20.48	7.75	2.48	1.99	1.79	3.28	0.89
retinoblastoma cell line:Y79	10475-106I7	15.33	53.78	7.53	5.20	3.64	0.52	0.52	4.42
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.17	45.49	1.35	2.34	0.86	1.72	3.44	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	167.31	84.36	9.84	2.81	3.09	3.37	1.97	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	59.87	3.79	2.27	0.00	1.52	0.76	1.52	0.00
salivary acinar cells, donor1	11771-123I7	21.85	5.99	3.08	0.81	1.13	0.65	0.49	0.65
salivary acinar cells, donor2	11772-123I8	19.00	4.13	1.79	1.51	1.65	0.83	0.41	0.55
salivary acinar cells, donor3	11773-123I9	54.29	2.65	3.31	0.00	2.65	1.32	5.30	0.00
salivary gland, adult, pool1	10093-102C3	23.45	20.02	25.74	0.57	0.57	4.58	1.14	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.10	18.21	1.60	1.01	1.10	1.43	3.96	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.46	18.10	0.94	1.88	0.71	1.65	3.76	0.94
seminal vesicle, adult	10201-103F3	193.64	54.49	22.22	12.17	6.35	7.94	2.65	7.94
serous adenocarcinoma cell line:JHOS-2	10639-108I9	24.29	7.77	1.21	0.73	0.24	0.97	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.65	8.81	1.01	0.50	0.75	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	49.17	29.10	3.01	1.00	2.01	2.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.54	0.00	0.00	0.13	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	73.50	46.53	5.19	4.64	1.55	1.66	1.88	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	46.84	49.42	6.71	1.55	2.71	0.52	1.55	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	52.49	7.80	2.84	2.84	4.26	1.42	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	39.46	4.80	1.80	0.96	1.68	0.72	0.96	0.60
skeletal muscle, fetal, donor1	10066-101I3	216.08	50.25	2.01	7.04	15.08	2.01	1.01	5.03
skin, adult, donor1	10074-102A2	54.28	27.14	0.00	0.00	6.79	0.00	6.79	6.79
skin, fetal, donor1	10065-101I2	195.05	69.43	1.89	7.57	4.42	5.05	0.63	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	6.67	1.00	0.00	0.33	0.00	0.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	77.86	9.77	0.95	3.15	1.58	0.63	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.58	16.38	8.29	4.05	2.70	2.51	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	47.80	61.98	12.36	5.11	2.14	2.14	0.82	3.30
small cell lung carcinoma cell line:NCI-H82	10842-111E5	22.36	12.87	3.70	2.25	2.09	0.64	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	14.82	2.18	1.09	0.65	0.22	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	215.36	42.40	11.11	6.69	5.02	1.55	1.19	3.94
small intestine, fetal, donor1	10064-101I1	131.69	29.24	1.23	4.42	5.41	1.23	0.49	4.18
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.87	2.56	0.00	0.51	1.03	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	73.40	5.69	1.81	1.29	1.29	2.07	2.07	0.26
somatostatinoma cell line:QGP-1	10781-110G7	15.01	0.80	0.00	0.00	0.27	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	93.14	8.95	4.59	2.98	1.38	1.61	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	66.24	5.91	0.39	2.37	1.58	0.39	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	85.78	12.45	1.38	0.00	1.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	128.07	31.71	0.61	6.10	3.05	3.05	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	88.17	15.61	0.00	0.92	1.84	0.92	0.92	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	42.86	9.11	1.19	1.34	0.75	2.54	0.90	0.60
spleen, adult, pool1	10025-101D7	77.31	49.12	4.07	3.52	3.74	1.10	1.10	3.08
spleen, fetal, pool1	10044-101F8	86.84	40.44	10.49	3.50	2.38	3.02	1.43	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.30	5.89	0.57	0.95	0.38	1.33	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.66	9.78	0.70	1.40	1.05	1.40	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.42	7.82	0.78	1.17	0.78	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.45	7.54	1.35	1.58	0.79	1.13	0.45	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.52	7.20	2.12	0.85	1.27	0.85	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	12.27	0.85	0.42	0.42	0.00	2.96	0.42
stomach, fetal, donor1	10062-101H8	226.41	81.17	1.07	9.61	12.82	5.34	6.41	6.41
submaxillary gland, adult	10202-103F4	26.21	22.79	2.85	2.85	0.57	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	162.82	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.96	3.53	1.45	2.08	0.62	0.62	1.45	0.42
substantia nigra, adult, donor10258	10371-105G2	59.48	15.52	1.55	0.00	1.55	1.03	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	160.39	33.92	0.00	4.95	3.53	0.00	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	139.16	80.24	8.25	6.88	6.19	5.96	2.52	5.73
temporal lobe, adult, pool1	10031-101E4	30.86	7.71	1.70	1.10	0.93	1.44	0.08	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	17.09	12.11	0.00	0.71	2.14	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.14	4.40	1.32	1.32	1.32	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	17.80	1.40	2.79	1.05	1.05	0.70	0.35	0.35
tenocyte, donor2	11765-123I1	22.13	5.72	1.91	1.53	0.76	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	22.24	6.30	2.59	2.97	0.74	0.74	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.17	53.54	3.57	1.70	1.70	1.19	1.02	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	43.16	67.98	1.85	3.55	2.62	1.39	0.62	1.54
teratocarcinoma cell line:PA-1	10807-111A6	77.02	76.71	4.49	5.89	4.18	1.39	0.46	4.34
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.37	17.90	0.89	1.52	0.89	1.40	0.63	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	31.39	2.27	2.27	0.76	2.27	0.38	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.90	4.04	11.45	0.76	0.76	7.20	0.44	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	39.41	57.32	0.98	5.21	2.61	2.28	0.98	3.58
testis, adult, pool1	10026-101D8	73.55	13.53	3.76	3.11	1.50	1.29	1.93	1.40
testis, adult, pool2	10096-102C6	49.62	12.63	5.86	2.26	0.90	0.45	0.90	0.90
thalamus - adult, donor10196	10168-103B6	196.51	51.89	12.14	6.62	8.83	2.21	0.00	6.62
thalamus, adult, donor10252	10154-103A1	48.92	10.31	4.53	4.84	0.31	0.78	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	81.60	78.52	1.54	0.00	7.70	3.08	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	91.57	40.84	6.42	11.69	3.95	2.14	1.32	2.31
thalamus, newborn, donor10223	10366-105F6	425.74	355.55	9.21	24.16	21.29	8.05	0.00	13.81
throat, adult	10209-103G2	56.18	10.99	4.99	3.75	2.00	1.00	1.75	0.50
throat, fetal, donor1	10061-101H7	113.35	31.38	0.91	4.88	2.74	2.13	1.52	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	27.62	13.32	4.17	1.79	0.40	0.20	0.99	0.60
thymus, adult, pool1	10027-101D9	33.40	4.37	0.70	0.60	0.60	1.59	0.30	0.50
thymus, fetal, pool1	10043-101F7	66.91	9.77	4.99	1.56	0.94	1.97	0.94	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.50	7.05	1.06	0.66	0.80	0.40	0.40	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	12.15	9.22	0.14	0.56	0.28	1.12	1.82	0.14
thyroid, adult, pool1	10028-101E1	60.84	12.60	4.76	1.12	1.03	1.77	1.31	1.12
thyroid, fetal, donor1	10060-101H6	113.64	15.29	1.58	4.22	2.11	3.69	1.85	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	113.95	36.96	3.08	6.16	0.00	3.08	0.00	9.24
tongue, adult	10203-103F5	29.77	8.61	2.09	1.63	1.63	0.93	0.70	1.40
tongue, fetal, donor1	10059-101H5	53.20	15.37	1.18	2.36	2.76	0.39	0.00	0.79
tonsil, adult, pool1	10047-101G2	35.86	9.72	1.50	0.80	0.60	0.70	1.70	0.60
trachea, adult, pool1	10029-101E2	54.72	14.64	3.03	1.23	1.64	1.88	2.13	0.57
trachea, fetal, donor1	10058-101H4	91.56	27.31	2.31	5.00	2.69	1.92	0.77	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.49	3.90	1.42	1.06	1.77	1.77	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	35.26	21.68	0.91	0.91	0.61	1.42	2.03	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.17	39.17	2.35	4.23	3.13	2.19	2.04	1.41
tridermal teratoma cell line:HGRT	10694-109G1	78.00	22.83	0.00	0.00	3.81	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	71.70	31.07	1.27	1.86	2.54	1.61	0.93	1.02
umbilical cord, fetal, donor1	10057-101H3	75.11	8.35	0.00	4.17	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	123.36	6.31	48.12	1.19	1.19	3.24	4.78	0.85
uterus, fetal, donor1	10055-101H1	101.87	6.66	2.56	4.10	2.05	1.02	2.56	0.51
vagina, adult	10204-103F6	69.79	1.29	5.17	1.29	1.29	0.65	3.23	0.00
vein, adult	10191-103E2	28.50	6.58	1.75	1.53	1.32	0.88	1.32	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00